CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pioglitazone
Accession: CHEBI:8228
browse the term
Definition: A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Synonyms: exact_synonym: 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
related_synonym: (+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; Formula=C19H20N2O3S; InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23); InChIKey=HYAFETHFCAUJAY-UHFFFAOYSA-N; SMILES=CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1; pioglitazona; pioglitazonum
xref: Beilstein:3595485; CAS:111025-46-8; Chemspider:4663; DrugBank:DB01132; Drug_Central:2179; HMDB:HMDB0015264; KEGG:C07675; KEGG:D08378; LINCS:LSM-1592
xref_mesh: MESH:C060836
xref: PMID:12879407; PMID:14522601; PMID:17628757; PMID:18215232; PMID:20797618; PMID:27842070; PMID:33798599; PMID:33864097; PMID:33983968; PMID:33995271; PMID:34006325; PMID:34009030; Patent:EP193256; Patent:US4687777; Reaxys:3595485; Wikipedia:Pioglitazone
G
ABAT
4-aminobutyrate aminotransferase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABAT mRNA
CTD
PMID:27935865
NCBI chr16:8,674,617...8,784,570
Ensembl chr16:8,674,596...8,784,575
G
ABCA1
ATP binding cassette subfamily A member 1
affects expression increases expression
EXP ISO
pioglitazone affects the expression of ABCA1 protein pioglitazone results in increased expression of ABCA1 mRNA; pioglitazone results in increased expression of ABCA1 protein
CTD
PMID:15381068 PMID:17961437 PMID:19201410
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCA4
ATP binding cassette subfamily A member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABCA4 mRNA
CTD
PMID:27935865
NCBI chr 1:93,992,834...94,121,148
Ensembl chr 1:93,992,834...94,121,148
G
ABCA6
ATP binding cassette subfamily A member 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABCA6 mRNA
CTD
PMID:27935865
NCBI chr17:69,078,702...69,141,895
Ensembl chr17:69,078,702...69,141,895
G
ABCA8
ATP binding cassette subfamily A member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABCA8B mRNA
CTD
PMID:27935865
NCBI chr17:68,867,289...68,955,392
Ensembl chr17:68,867,289...68,955,392
G
ABCB1
ATP binding cassette subfamily B member 1
increases expression
EXP
Pioglitazone results in increased expression of ABCB1 mRNA
CTD
PMID:31233785
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB11
ATP binding cassette subfamily B member 11
decreases activity
EXP
pioglitazone results in decreased activity of ABCB11 protein
CTD
PMID:20829430 PMID:22646477 PMID:23956101
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC9
ATP binding cassette subfamily C member 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABCC9 mRNA
CTD
PMID:27935865
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ABI3BP
ABI family member 3 binding protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABI3BP mRNA
CTD
PMID:27935865
NCBI chr 3:100,749,156...100,993,421
Ensembl chr 3:100,749,156...100,993,515
G
ABLIM2
actin binding LIM protein family member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABLIM2 mRNA
CTD
PMID:27935865
NCBI chr 4:7,965,327...8,158,813
Ensembl chr 4:7,965,310...8,158,832
G
ABRA
actin binding Rho activating protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABRA mRNA
CTD
PMID:27935865
NCBI chr 8:106,759,483...106,770,244
Ensembl chr 8:106,759,483...106,770,244
G
ACAT1
acetyl-CoA acetyltransferase 1
decreases expression
EXP
pioglitazone results in decreased expression of ACAT1 mRNA
CTD
PMID:15381068
NCBI chr11:108,116,705...108,147,603
Ensembl chr11:108,116,695...108,147,603
G
ACAT2
acetyl-CoA acetyltransferase 2
decreases expression
EXP
Pioglitazone results in decreased expression of ACAT2 mRNA
CTD
PMID:30031879
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACE
angiotensin I converting enzyme
multiple interactions
ISO
pioglitazone inhibits the reaction [Streptozocin results in increased expression of ACE mRNA]; pioglitazone inhibits the reaction [Streptozocin results in increased expression of ACE protein]
CTD
PMID:16979161
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
increases expression increases secretion
ISO
Pioglitazone results in increased expression of ACE2 protein Pioglitazone results in increased secretion of ACE2 protein
CTD
PMID:24114819 PMID:24558317
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACOD1
aconitate decarboxylase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of ACOD1 mRNA
CTD
PMID:27935865
NCBI chr13:76,948,511...76,958,638
Ensembl chr13:76,948,511...76,958,638
G
ACTA1
actin alpha 1, skeletal muscle
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTA1 mRNA
CTD
PMID:27935865
NCBI chr 1:229,431,245...229,434,094
Ensembl chr 1:229,430,365...229,434,104
G
ACTA2
actin alpha 2, smooth muscle
multiple interactions
ISO EXP
pioglitazone inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACTA2 mRNA]; pioglitazone inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] Pioglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] pioglitazone affects the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]
CTD
PMID:15052691 PMID:16484506 PMID:18513333 PMID:32613381
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
G
ACTC1
actin alpha cardiac muscle 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTC1 mRNA
CTD
PMID:27935865
NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
G
ACTG2
actin gamma 2, smooth muscle
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTG2 mRNA
CTD
PMID:27935865
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
G
ACTN2
actinin alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTN2 mRNA
CTD
PMID:27935865
NCBI chr 1:236,686,499...236,764,631
Ensembl chr 1:236,664,141...236,764,631
G
ADAM23
ADAM metallopeptidase domain 23
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADAM23 mRNA
CTD
PMID:27935865
NCBI chr 2:206,443,532...206,621,127
Ensembl chr 2:206,443,532...206,621,127
G
ADAM5
ADAM metallopeptidase domain 5 (pseudogene)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADAM5 mRNA
CTD
PMID:27935865
NCBI chr 8:39,314,632...39,417,378
Ensembl chr 8:39,314,591...39,417,378
G
ADAM9
ADAM metallopeptidase domain 9
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]
CTD
PMID:20847119
NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445
G
ADCY5
adenylate cyclase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADCY5 mRNA
CTD
PMID:27935865
NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090
G
ADCYAP1R1
ADCYAP receptor type I
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADCYAP1R1 mRNA
CTD
PMID:27935865
NCBI chr 7:31,052,308...31,111,474
Ensembl chr 7:31,052,308...31,111,474
G
ADHFE1
alcohol dehydrogenase iron containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADHFE1 mRNA
CTD
PMID:27935865
NCBI chr 8:66,432,504...66,468,907
Ensembl chr 8:66,432,492...66,468,907
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
multiple interactions decreases expression increases expression
ISO EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone results in increased expression of ADIPOQ mRNA]; [N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of ADIPOQ mRNA; [Sodium Glutamate co-treated with Pioglitazone] results in increased expression of ADIPOQ protein; Pioglitazone promotes the reaction [Palmitates results in increased secretion of ADIPOQ protein]; PPARG protein affects the reaction [Pioglitazone results in increased expression of ADIPOQ mRNA] Pioglitazone results in decreased expression of ADIPOQ protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; octocrylene inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; T 0070907 inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]] Pioglitazone inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]; Pioglitazone inhibits the reaction [Fructose results in decreased secretion of ADIPOQ protein] pioglitazone results in increased expression of ADIPOQ mRNA; pioglitazone results in increased expression of ADIPOQ protein
CTD
PMID:12927809 PMID:18303122 PMID:18513333 PMID:18815186 PMID:19048458 PMID:24622831 PMID:25679220 PMID:27918843 PMID:27935865 PMID:31016361 PMID:32407875 PMID:34864131 More...
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADM
adrenomedullin
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA
CTD
PMID:20847119
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
ADORA1
adenosine A1 receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADORA1 mRNA
CTD
PMID:27935865
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
AGBL1
AGBL carboxypeptidase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AGBL1 mRNA
CTD
PMID:27935865
NCBI chr15:86,079,620...87,031,476
Ensembl chr15:86,079,871...87,049,169
G
AGER
advanced glycosylation end-product specific receptor
multiple interactions
ISO
Pioglitazone inhibits the reaction [Fructose results in increased expression of AGER protein]
CTD
PMID:25679220
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
multiple interactions
ISO
pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 mRNA]; pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 protein]
CTD
PMID:25874449
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AGTR1A mRNA
CTD
PMID:27935865
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AGTR2
angiotensin II receptor type 2
multiple interactions
ISO
[ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein]; [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AGTR2 mRNA
CTD
PMID:15992368 PMID:27935865
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
G
AIFM3
apoptosis inducing factor mitochondria associated 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AIFM3 mRNA
CTD
PMID:27935865
NCBI chr22:20,965,172...20,981,358
Ensembl chr22:20,965,108...20,981,360
G
AJUBA
ajuba LIM protein
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA
CTD
PMID:20847119
NCBI chr14:22,971,177...22,982,551
Ensembl chr14:22,971,177...22,982,551
G
ALPK3
alpha kinase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ALPK3 mRNA
CTD
PMID:27935865
NCBI chr15:84,817,356...84,873,479
Ensembl chr15:84,817,356...84,873,479
G
AMIGO2
adhesion molecule with Ig like domain 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AMIGO2 mRNA
CTD
PMID:27935865
NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959
G
AMOTL2
angiomotin like 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA
CTD
PMID:20847119
NCBI chr 3:134,355,345...134,375,417
Ensembl chr 3:134,355,347...134,375,479
G
AMPD1
adenosine monophosphate deaminase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AMPD1 mRNA
CTD
PMID:27935865
NCBI chr 1:114,673,098...114,695,546
Ensembl chr 1:114,673,090...114,695,618
G
ANGPT2
angiopoietin 2
multiple interactions
ISO
[ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein]
CTD
PMID:15992368
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
G
ANGPTL2
angiopoietin like 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]
CTD
PMID:20847119
NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,635
G
ANGPTL4
angiopoietin like 4
increases expression
EXP
Pioglitazone results in increased expression of ANGPTL4 mRNA
CTD
PMID:30031879
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
G
ANK1
ankyrin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ANK1 mRNA
CTD
PMID:27935865
NCBI chr 8:41,653,225...41,896,741
Ensembl chr 8:41,653,220...41,896,741
G
ANKRD37
ankyrin repeat domain 37
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
G
ANKRD63
ankyrin repeat domain 63
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ANKRD63 mRNA
CTD
PMID:27935865
NCBI chr15:40,278,372...40,283,064
Ensembl chr15:40,278,372...40,283,064
G
ANO5
anoctamin 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ANO5 mRNA
CTD
PMID:27935865
NCBI chr11:22,192,473...22,283,357
Ensembl chr11:21,782,659...22,283,567
G
ANOS1
anosmin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of WFDC17 mRNA
CTD
PMID:27935865
NCBI chr X:8,528,874...8,732,137
Ensembl chr X:8,528,874...8,732,137
G
AOC3
amine oxidase copper containing 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AOC3 mRNA
CTD
PMID:27935865
NCBI chr17:42,851,199...42,858,124
Ensembl chr17:42,851,184...42,858,130
G
AP1S2
adaptor related protein complex 1 subunit sigma 2
decreases expression
EXP
Pioglitazone results in decreased expression of AP1S2 mRNA
CTD
PMID:30031879
NCBI chr X:15,825,806...15,854,813
Ensembl chr X:15,825,806...15,854,931
G
APC2
APC regulator of WNT signaling pathway 2
increases expression
ISO
pioglitazone results in increased expression of APC2 mRNA
CTD
PMID:21347706
NCBI chr19:1,446,230...1,473,244
Ensembl chr19:1,446,302...1,473,244
G
APOB
apolipoprotein B
decreases expression
EXP
pioglitazone results in decreased expression of APOB protein
CTD
PMID:16324916
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC1
apolipoprotein C1
multiple interactions
EXP
[Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in increased expression of APOC1 protein
CTD
PMID:16324916
NCBI chr19:44,914,325...44,919,346
Ensembl chr19:44,914,247...44,919,349
G
APOC2
apolipoprotein C2
multiple interactions
EXP ISO
[Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in decreased expression of APOC2 protein [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of APOC2 mRNA
CTD
PMID:16324916 PMID:27935865
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOC3
apolipoprotein C3
multiple interactions
EXP
[Ephedrine co-treated with Caffeine co-treated with pioglitazone] results in decreased expression of APOC3 protein
CTD
PMID:16324916
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOL6
apolipoprotein L6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of APOL6 mRNA
CTD
PMID:27935865
NCBI chr22:35,648,446...35,668,404
Ensembl chr22:35,648,446...35,668,404
G
APP
amyloid beta precursor protein
decreases expression multiple interactions
EXP ISO
pioglitazone results in decreased expression of APP protein mutant form pioglitazone inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]
CTD
PMID:14586007 PMID:15817521 PMID:16407166
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
AQP7
aquaporin 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AQP7 mRNA
CTD
PMID:27935865
NCBI chr 9:33,383,191...33,402,568
Ensembl chr 9:33,383,179...33,402,682
G
AR
androgen receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AR mRNA
CTD
PMID:27935865
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
AREG
amphiregulin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of AREG mRNA
CTD
PMID:27935865
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ARMCX2
armadillo repeat containing X-linked 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ARMCX2 mRNA
CTD
PMID:27935865
NCBI chr X:101,655,281...101,659,850
Ensembl chr X:101,655,281...101,659,850
G
ART1
ADP-ribosyltransferase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ART1 mRNA
CTD
PMID:27935865
NCBI chr11:3,645,128...3,664,416
Ensembl chr11:3,645,128...3,664,416
G
ART2P
ADP-ribosyltransferase 2, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of ART2A mRNA
CTD
PMID:27935865
NCBI chr11:72,520,951...72,521,640
Ensembl chr11:72,519,986...72,521,733
G
ASB10
ankyrin repeat and SOCS box containing 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ASB10 mRNA
CTD
PMID:27935865
NCBI chr 7:151,175,698...151,187,792
Ensembl chr 7:151,175,698...151,187,832
G
ASB14
ankyrin repeat and SOCS box containing 14
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ASB14 mRNA
CTD
PMID:27935865
NCBI chr 3:57,268,342...57,292,685
Ensembl chr 3:57,268,342...57,292,685
G
ASB5
ankyrin repeat and SOCS box containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ASB5 mRNA
CTD
PMID:27935865
NCBI chr 4:176,213,673...176,277,524
Ensembl chr 4:176,213,673...176,277,571
G
ATF3
activating transcription factor 3
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA
CTD
PMID:20847119
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
ATP1A2
ATPase Na+/K+ transporting subunit alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ATP1A2 mRNA
CTD
PMID:27935865
NCBI chr 1:160,115,759...160,143,591
Ensembl chr 1:160,115,759...160,143,591
G
ATP2A1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ATP2A1 mRNA
CTD
PMID:27935865
NCBI chr16:28,878,488...28,904,466
Ensembl chr16:28,878,405...28,904,466
G
ATP5F1B
ATP synthase F1 subunit beta
decreases expression
EXP
pioglitazone results in decreased expression of ATP5F1B mRNA
CTD
PMID:20860658
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
G
AVPR1A
arginine vasopressin receptor 1A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of AVPR1A mRNA
CTD
PMID:27935865
NCBI chr12:63,142,759...63,151,201
Ensembl chr12:63,142,759...63,151,201
G
B4GALNT2
beta-1,4-N-acetyl-galactosaminyltransferase 2 (SID blood group)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of B4GALNT2 mRNA
CTD
PMID:27935865
NCBI chr17:49,120,344...49,176,840
Ensembl chr17:49,132,460...49,176,840
G
B4GALNT3
beta-1,4-N-acetyl-galactosaminyltransferase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of B4GALNT3 mRNA
CTD
PMID:27935865
NCBI chr12:459,939...563,509
Ensembl chr12:459,939...563,509
G
BACE1
beta-secretase 1
multiple interactions decreases expression decreases activity
EXP ISO
pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein] pioglitazone results in decreased expression of BACE1 mRNA pioglitazone results in decreased activity of BACE1 protein pioglitazone results in decreased expression of BACE1 mRNA; pioglitazone results in decreased expression of BACE1 protein
CTD
PMID:14586007 PMID:15817521 PMID:16407166
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of BAX mRNA]
CTD
PMID:30130594
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCHE
butyrylcholinesterase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of BCHE mRNA
CTD
PMID:27935865
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BCL11A
BCL11 transcription factor A
decreases expression
EXP
Pioglitazone results in decreased expression of BCL11A mRNA
CTD
PMID:30031879
NCBI chr 2:60,450,520...60,553,924
Ensembl chr 2:60,450,520...60,554,467
G
BCL2
BCL2 apoptosis regulator
multiple interactions
ISO
[naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of BCL2 mRNA]
CTD
PMID:30130594
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BDNF
brain derived neurotrophic factor
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BDNF protein]
CTD
PMID:32735850
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BEND5
BEN domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of BEND5 mRNA
CTD
PMID:27935865
NCBI chr 1:48,727,519...48,776,891
Ensembl chr 1:48,727,519...48,776,969
G
BGLAP
bone gamma-carboxyglutamate protein
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]
CTD
PMID:32473317
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
G
BHLHA15
basic helix-loop-helix family member a15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of BHLHA15 mRNA
CTD
PMID:27935865
NCBI chr 7:98,211,439...98,215,457
Ensembl chr 7:98,211,439...98,215,457
G
BIRC3
baculoviral IAP repeat containing 3
decreases expression
EXP
Pioglitazone results in decreased expression of BIRC3 mRNA
CTD
PMID:30031879
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
BMP6
bone morphogenetic protein 6
increases expression
EXP
Pioglitazone results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BPIFA4P
BPI fold containing family A member 4, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of BPIFA5 mRNA
CTD
PMID:27935865
NCBI chr20:33,193,605...33,210,462
Ensembl chr20:33,193,585...33,210,462 Ensembl chr20:33,193,585...33,210,462
G
BPIFB1
BPI fold containing family B member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of BPIFB1 mRNA
CTD
PMID:27935865
NCBI chr20:33,283,214...33,309,871
Ensembl chr20:33,273,480...33,309,871
G
BSG
basigin (Ok blood group)
multiple interactions decreases expression
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] pioglitazone results in decreased expression of BSG protein
CTD
PMID:16860414 PMID:17007354 PMID:17055343
NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
G
BTN2A2
butyrophilin subfamily 2 member A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of BTN2A2 mRNA
CTD
PMID:27935865
NCBI chr 6:26,383,108...26,394,874
Ensembl chr 6:26,383,096...26,394,874
G
BZW1
basic leucine zipper and W2 domains 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 2:200,811,589...200,827,338
Ensembl chr 2:200,810,594...200,827,338
G
C1orf54
chromosome 1 open reading frame 54
decreases expression
EXP
Pioglitazone results in decreased expression of C1ORF54 mRNA
CTD
PMID:30031879
NCBI chr 1:150,268,731...150,280,924
Ensembl chr 1:150,268,200...150,280,916
G
C1QTNF7
C1q and TNF related 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of C1QTNF7 mRNA
CTD
PMID:27935865
NCBI chr 4:15,339,786...15,446,167
Ensembl chr 4:15,339,818...15,446,167
G
C4A
complement C4A (Chido/Rodgers blood group)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of C4A mRNA
CTD
PMID:27935865
NCBI chr 6:31,982,057...32,002,681
Ensembl chr 6:31,982,057...32,002,681
G
C5AR1
complement C5a receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of C5AR1 mRNA
CTD
PMID:27935865
NCBI chr19:47,307,477...47,322,066
Ensembl chr19:47,290,023...47,322,066
G
CA3
carbonic anhydrase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CAR3 mRNA
CTD
PMID:27935865
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CABCOCO1
ciliary associated calcium binding coiled-coil 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CABCOCO1 mRNA
CTD
PMID:27935865
NCBI chr10:61,662,929...61,766,766
Ensembl chr10:61,662,929...61,766,766
G
CACNA1C
calcium voltage-gated channel subunit alpha1 C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CACNA1C mRNA
CTD
PMID:27935865
NCBI chr12:1,970,780...2,697,950
Ensembl chr12:1,970,772...2,697,950
G
CACNA1S
calcium voltage-gated channel subunit alpha1 S
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CACNA1S mRNA
CTD
PMID:27935865
NCBI chr 1:201,039,512...201,112,426
Ensembl chr 1:201,039,512...201,112,451
G
CACNA2D3
calcium voltage-gated channel auxiliary subunit alpha2delta 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CACNA2D3 mRNA
CTD
PMID:27935865
NCBI chr 3:54,122,552...55,074,557
Ensembl chr 3:54,122,552...55,074,557
G
CADM2
cell adhesion molecule 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CADM2 mRNA
CTD
PMID:27935865
NCBI chr 3:84,958,989...86,074,429
Ensembl chr 3:84,958,989...86,074,429
G
CALHM5
calcium homeostasis modulator family member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CALHM5 mRNA
CTD
PMID:27935865
NCBI chr 6:116,511,639...116,524,788
Ensembl chr 6:116,511,639...116,524,788
G
CASP3
caspase 3
multiple interactions
ISO
pioglitazone inhibits the reaction [Galactose results in increased activity of CASP3 protein] [Fenofibrate co-treated with Pioglitazone] inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]; Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of CASP3 mRNA]
CTD
PMID:23795773 PMID:30130594 PMID:36988379
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASQ1
calsequestrin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CASQ1 mRNA
CTD
PMID:27935865
NCBI chr 1:160,190,575...160,201,886
Ensembl chr 1:160,190,575...160,201,886
G
CAT
catalase
multiple interactions
ISO
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased activity of CAT protein]]; Pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased activity of CAT protein]; Pioglitazone inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased activity of CAT protein]; Pioglitazone inhibits the reaction [Streptozocin results in decreased activity of CAT protein] Pioglitazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased activity of CAT protein]
CTD
PMID:20450929 PMID:27350165 PMID:29233026 PMID:29247773 PMID:32735850
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV1
caveolin 1
affects expression
EXP
pioglitazone affects the expression of CAV1 protein
CTD
PMID:17961437
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
CAV3
caveolin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CAV3 mRNA
CTD
PMID:27935865
NCBI chr 3:8,733,802...8,746,758
Ensembl chr 3:8,733,802...8,841,808
G
CCDC159
coiled-coil domain containing 159
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CCDC159 mRNA
CTD
PMID:27935865
NCBI chr19:11,346,519...11,354,944
Ensembl chr19:11,344,684...11,354,944
G
CCDC85A
coiled-coil domain containing 85A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CCDC85A mRNA
CTD
PMID:27935865
NCBI chr 2:56,183,852...56,386,174
Ensembl chr 2:56,183,990...56,386,172
G
CCL11
C-C motif chemokine ligand 11
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL11 protein]
CTD
PMID:17015710
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
EXP ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein] [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL2 mRNA
CTD
PMID:20847119 PMID:27935865 PMID:32613381
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL3
C-C motif chemokine ligand 3
multiple interactions decreases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL3 mRNA Pioglitazone results in decreased expression of CCL3 mRNA
CTD
PMID:27935865 PMID:30031879
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL3L1
C-C motif chemokine ligand 3 like 1
decreases expression
EXP
Pioglitazone results in decreased expression of CCL3L1 mRNA
CTD
PMID:30031879
Ensembl chr17:36,194,869...36,196,758
G
CCL3L3
C-C motif chemokine ligand 3 like 3
decreases expression
EXP
Pioglitazone results in decreased expression of CCL3L3 mRNA
CTD
PMID:30031879
NCBI chr17:36,194,869...36,196,758
Ensembl chr17:36,194,869...36,196,758
G
CCL5
C-C motif chemokine ligand 5
multiple interactions decreases response to substance
ISO EXP
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] pioglitazone results in decreased susceptibility to CCL5 protein
CTD
PMID:17015710 PMID:18158351
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL7 mRNA
CTD
PMID:27935865
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCN2
cellular communication network factor 2
multiple interactions
EXP ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] Pioglitazone affects the reaction [Carbon Tetrachloride results in increased expression of CCN2 mRNA]
CTD
PMID:16484506 PMID:20847119
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNA1
cyclin A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CCNA1 mRNA
CTD
PMID:27935865
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
G
CCNA2
cyclin A2
decreases expression
EXP
pioglitazone results in decreased expression of CCNA2 protein
CTD
PMID:15729575
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCNB1
cyclin B1
decreases expression
EXP
pioglitazone results in decreased expression of CCNB1 protein
CTD
PMID:15729575
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCND1
cyclin D1
decreases expression multiple interactions
ISO EXP
pioglitazone results in decreased expression of CCND1 mRNA; pioglitazone results in decreased expression of CCND1 protein pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CCND1 protein] Pioglitazone results in decreased expression of CCND1 mRNA
CTD
PMID:17077279 PMID:26643070 PMID:30031879
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCND3
cyclin D3
decreases expression
EXP
pioglitazone results in decreased expression of CCND3 protein
CTD
PMID:15729575
NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357
G
CCNE1
cyclin E1
decreases expression
EXP
pioglitazone results in decreased expression of CCNE1 protein
CTD
PMID:15729575
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CCNO
cyclin O
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CCNO mRNA
CTD
PMID:27935865
NCBI chr 5:55,231,152...55,233,608
Ensembl chr 5:55,231,152...55,233,608
G
CD36
CD36 molecule (CD36 blood group)
increases expression multiple interactions
EXP ISO
Pioglitazone results in increased expression of CD36 mRNA; Pioglitazone results in increased expression of CD36 protein Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; PPARG protein affects the reaction [Pioglitazone results in increased expression of CD36 protein] [pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of CD36 mRNA pioglitazone results in increased expression of CD36 mRNA
CTD
PMID:15381068 PMID:16484506 PMID:17143554 PMID:19048458 PMID:20723549 PMID:26643070 PMID:28263783 PMID:30031879 PMID:32613381 More...
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD84
CD84 molecule
decreases expression
EXP
Pioglitazone results in decreased expression of CD84 mRNA
CTD
PMID:30031879
NCBI chr 1:160,541,098...160,579,496
Ensembl chr 1:160,541,095...160,579,516
G
CDC20B
cell division cycle 20B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CDC20B mRNA
CTD
PMID:27935865
NCBI chr 5:55,112,971...55,173,177
Ensembl chr 5:55,112,971...55,173,177
G
CDC42
cell division cycle 42
decreases expression
EXP
Pioglitazone results in decreased expression of CDC42 mRNA
CTD
PMID:32589349
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
G
CDK2
cyclin dependent kinase 2
decreases expression
EXP
pioglitazone results in decreased expression of CDK2 protein
CTD
PMID:15729575
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDKL1
cyclin dependent kinase like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CDKL1 mRNA
CTD
PMID:27935865
NCBI chr14:50,326,265...50,397,298
Ensembl chr14:50,326,265...50,416,461
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions decreases expression
ISO EXP
pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]]; pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in increased expression of CDKN1A protein]]; Pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CDKN1A protein]; Pioglitazone inhibits the reaction [Indican results in increased expression of CDKN1A protein]; Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in increased expression of CDKN1A protein]]; PRNP protein promotes the reaction [Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in increased expression of CDKN1A protein]]]; PRNP protein promotes the reaction [Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in increased expression of CDKN1A protein]]] pioglitazone results in decreased expression of CDKN1A protein
CTD
PMID:15729575 PMID:17582756 PMID:26643070 PMID:29734669
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
multiple interactions increases expression
ISO EXP
pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]]; pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] pioglitazone results in increased expression of CDKN1B protein pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein]; PRKAA1 protein affects the reaction [pioglitazone results in increased expression of CDKN1B protein]
CTD
PMID:17582756 PMID:26643070
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CDKN1C
cyclin dependent kinase inhibitor 1C
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA
CTD
PMID:20847119
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CEBPA
CCAAT enhancer binding protein alpha
increases expression
ISO
pioglitazone results in increased expression of CEBPA mRNA
CTD
PMID:28242381
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CEMIP
cell migration inducing hyaluronidase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CEMIP mRNA
CTD
PMID:27935865
NCBI chr15:80,779,370...80,951,771
Ensembl chr15:80,779,343...80,951,776
G
CES1
carboxylesterase 1
increases expression
EXP
pioglitazone results in increased expression of CES1 mRNA
CTD
PMID:15381068
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CFD
complement factor D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CFD mRNA
CTD
PMID:27935865
NCBI chr19:859,664...863,641
Ensembl chr19:859,453...867,884
G
CGB1
chorionic gonadotropin subunit beta 1
increases expression
EXP
Pioglitazone results in increased expression of CGB1 mRNA
CTD
PMID:30031879
NCBI chr19:49,035,569...49,036,895
Ensembl chr19:49,035,569...49,036,895
G
CGB5
chorionic gonadotropin subunit beta 5
increases expression
EXP
Pioglitazone results in increased expression of CGB5 mRNA
CTD
PMID:30031879
NCBI chr19:49,043,848...49,045,311
Ensembl chr19:49,043,848...49,045,311
G
CHCHD6
coiled-coil-helix-coiled-coil-helix domain containing 6
decreases expression
EXP
Pioglitazone results in decreased expression of CHCHD6 mRNA
CTD
PMID:30031879
NCBI chr 3:126,704,240...126,960,420
Ensembl chr 3:126,704,240...126,960,420
G
CHI3L1
chitinase 3 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of CHI3L1 mRNA
CTD
PMID:27935865
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CHIT1
chitinase 1
decreases expression
EXP
Pioglitazone results in decreased expression of CHIT1 mRNA
CTD
PMID:30031879
NCBI chr 1:203,216,079...203,230,099
Ensembl chr 1:203,212,827...203,273,641
G
CHP2
calcineurin like EF-hand protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CHP2 mRNA
CTD
PMID:27935865
NCBI chr16:23,755,026...23,758,935
Ensembl chr16:23,755,026...23,758,935
G
CHRM1
cholinergic receptor muscarinic 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CHRM1 mRNA
CTD
PMID:27935865
NCBI chr11:62,908,679...62,921,878
Ensembl chr11:62,908,679...62,921,807
G
CHRM2
cholinergic receptor muscarinic 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CHRM2 mRNA
CTD
PMID:27935865
NCBI chr 7:136,868,652...137,020,213
Ensembl chr 7:136,868,652...137,020,255
G
CHRNA1
cholinergic receptor nicotinic alpha 1 subunit
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CHRNA1 mRNA
CTD
PMID:27935865
NCBI chr 2:174,747,592...174,764,472
Ensembl chr 2:174,747,592...174,787,935
G
CHRNE
cholinergic receptor nicotinic epsilon subunit
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CHRNE mRNA
CTD
PMID:27935865
NCBI chr17:4,897,771...4,908,677
Ensembl chr17:4,897,771...4,934,438
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of CHUK mRNA
CTD
PMID:32589349
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
G
CIDEC
cell death inducing DFFA like effector c
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CIDEC mRNA
CTD
PMID:27935865
NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255
G
CKM
creatine kinase, M-type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CKM mRNA
CTD
PMID:27935865
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
G
CKMT2
creatine kinase, mitochondrial 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CKMT2 mRNA
CTD
PMID:27935865
NCBI chr 5:81,233,322...81,266,398
Ensembl chr 5:81,233,320...81,266,398
G
CLEC14A
C-type lectin domain containing 14A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CLEC14A mRNA
CTD
PMID:27935865
NCBI chr14:38,254,000...38,256,093
Ensembl chr14:38,254,000...38,256,093
G
CLEC1A
C-type lectin domain family 1 member A
increases expression
EXP
Pioglitazone results in increased expression of CLEC1A mRNA
CTD
PMID:30031879
NCBI chr12:10,069,554...10,098,985
Ensembl chr12:10,069,554...10,111,627
G
CLEC4A
C-type lectin domain family 4 member A
decreases expression
EXP
Pioglitazone results in decreased expression of CLEC4A mRNA
CTD
PMID:30031879
NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607
G
CLEC4D
C-type lectin domain family 4 member D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CLEC4D mRNA
CTD
PMID:27935865
NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366
G
CLEC4E
C-type lectin domain family 4 member E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CLEC4E mRNA
CTD
PMID:27935865
NCBI chr12:8,533,275...8,540,905
Ensembl chr12:8,533,305...8,540,905
G
CLSTN3
calsyntenin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CLSTN3 mRNA
CTD
PMID:27935865
NCBI chr12:7,129,093...7,158,945
Ensembl chr12:7,129,698...7,158,945
G
CMYA5
cardiomyopathy associated 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CMYA5 mRNA
CTD
PMID:27935865
NCBI chr 5:79,689,836...79,800,222
Ensembl chr 5:79,689,836...79,800,240
G
CNGA3
cyclic nucleotide gated channel subunit alpha 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CNGA3 mRNA
CTD
PMID:27935865
NCBI chr 2:98,346,456...98,398,601
Ensembl chr 2:98,346,188...98,398,601
G
CNN1
calponin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CNN1 mRNA
CTD
PMID:27935865
NCBI chr19:11,538,851...11,550,323
Ensembl chr19:11,538,767...11,550,323
G
CNRIP1
cannabinoid receptor interacting protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CNRIP1 mRNA
CTD
PMID:27935865
NCBI chr 2:68,284,171...68,319,949
Ensembl chr 2:68,284,171...68,320,051
G
CNTD1
cyclin N-terminal domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CNTD1 mRNA
CTD
PMID:27935865
NCBI chr17:42,798,785...42,811,587
Ensembl chr17:42,798,800...42,811,587
G
COG8
component of oligomeric golgi complex 8
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA
CTD
PMID:20847119
NCBI chr16:69,326,428...69,339,564
Ensembl chr16:69,320,140...69,339,583
G
COL6A5
collagen type VI alpha 5 chain
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of COL6A5 mRNA
CTD
PMID:27935865
NCBI chr 3:130,345,672...130,484,846
Ensembl chr 3:130,345,516...130,484,846
G
CORO6
coronin 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CORO6 mRNA
CTD
PMID:27935865
NCBI chr17:29,614,762...29,622,912
Ensembl chr17:29,614,756...29,622,912
G
COX6A2
cytochrome c oxidase subunit 6A2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of COX6A2 mRNA
CTD
PMID:27935865
NCBI chr16:31,427,731...31,428,360
Ensembl chr16:31,427,731...31,428,360
G
COX8BP
cytochrome c oxidase subunit 8B, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of COX8B mRNA
CTD
PMID:27935865
NCBI chr11:253,417...256,972
Ensembl chr11:253,446...253,558
G
CPT1A
carnitine palmitoyltransferase 1A
multiple interactions
EXP
Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]
CTD
PMID:32613381
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CPT1B
carnitine palmitoyltransferase 1B
increases expression
ISO
pioglitazone results in increased expression of CPT1B mRNA
CTD
PMID:20723549
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
G
CPXM1
carboxypeptidase X, M14 family member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CPXM1 mRNA
CTD
PMID:27935865
NCBI chr20:2,794,074...2,800,627
Ensembl chr20:2,794,074...2,800,627
G
CPZ
carboxypeptidase Z
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CPZ mRNA
CTD
PMID:27935865
NCBI chr 4:8,592,765...8,619,752
Ensembl chr 4:8,592,660...8,619,759
G
CREB1
cAMP responsive element binding protein 1
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CREB1 protein]
CTD
PMID:32735850
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CRH
corticotropin releasing hormone
increases expression
EXP
Pioglitazone results in increased expression of CRH mRNA
CTD
PMID:30031879
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CRHR2
corticotropin releasing hormone receptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CRHR2 mRNA
CTD
PMID:27935865
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
G
CRISPLD1
cysteine rich secretory protein LCCL domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CRISPLD1 mRNA
CTD
PMID:27935865
NCBI chr 8:74,984,505...75,034,558
Ensembl chr 8:74,984,505...75,034,558
G
CRP
C-reactive protein
affects expression decreases expression
ISO EXP
pioglitazone affects the expression of CRP protein Pioglitazone results in decreased expression of CRP protein
CTD
PMID:28705172 PMID:28744220
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CRYAB
crystallin alpha B
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]
CTD
PMID:20847119
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
G
CRYM
crystallin mu
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CRYM mRNA
CTD
PMID:27935865
NCBI chr16:21,258,521...21,303,062
Ensembl chr16:21,238,874...21,303,083
G
CSHL1
chorionic somatomammotropin hormone like 1
increases expression
EXP
Pioglitazone results in increased expression of CSHL1 mRNA
CTD
PMID:30031879
NCBI chr17:63,909,608...63,911,258
Ensembl chr17:63,909,597...63,911,341
G
CSN1S1
casein alpha s1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CSN1S1 mRNA
CTD
PMID:27935865
NCBI chr 4:69,931,068...69,946,574
Ensembl chr 4:69,931,068...69,946,574
G
CSRP3
cysteine and glycine rich protein 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CSRP3 mRNA
CTD
PMID:27935865
NCBI chr11:19,182,030...19,201,983
Ensembl chr11:19,182,030...19,210,571
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CTLA4 mRNA
CTD
PMID:27935865
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTNNB1
catenin beta 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA
CTD
PMID:20847119
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CXCL1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CXCL3 mRNA
CTD
PMID:27935865
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL12
C-X-C motif chemokine ligand 12
decreases response to substance multiple interactions
EXP ISO
pioglitazone results in decreased susceptibility to CXCL12 protein [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CXCL12 mRNA pioglitazone inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]
CTD
PMID:18158351 PMID:27935865
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CXCL2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CXCL2 mRNA; [pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of CXCL2 mRNA
CTD
PMID:27935865 PMID:28263783
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL5
C-X-C motif chemokine ligand 5
multiple interactions
EXP
Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]
CTD
PMID:32613381
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
G
CXCL6
C-X-C motif chemokine ligand 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of CXCL5 mRNA
CTD
PMID:27935865
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression decreases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of CXCL15 mRNA Pioglitazone results in increased expression of CXCL8 mRNA Pioglitazone results in decreased expression of CXCL8 mRNA
CTD
PMID:27935865 PMID:30031879 PMID:32816093
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR3
C-X-C motif chemokine receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CXCR3 mRNA
CTD
PMID:27935865
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CXCR4
C-X-C motif chemokine receptor 4
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA
CTD
PMID:20847119
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYBA
cytochrome b-245 alpha chain
decreases expression affects activity
EXP ISO
pioglitazone results in decreased expression of CYBA mRNA pioglitazone affects the activity of CYBA protein
CTD
PMID:11172467 PMID:21962020
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
multiple interactions decreases expression decreases activity
EXP
pioglitazone inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased activity of CYP17A1 protein]; pioglitazone inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of CYP17A1 mRNA] pioglitazone results in decreased expression of CYP17A1 mRNA pioglitazone results in decreased activity of CYP17A1 protein
CTD
PMID:15072549 PMID:17138841
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
increases expression
EXP ISO
pioglitazone results in increased expression of CYP2B6 protein Pioglitazone results in increased expression of CYP2B10 mRNA
CTD
PMID:12642470 PMID:28541575
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C8
cytochrome P450 family 2 subfamily C member 8
multiple interactions increases expression affects metabolic processing decreases activity
EXP
Gemfibrozil inhibits the reaction [CYP2C8 protein affects the metabolism of pioglitazone] Pioglitazone results in increased expression of CYP2C8 mRNA pioglitazone results in decreased activity of CYP2C8 protein
CTD
PMID:12642470 PMID:15900286 PMID:31233785
NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CYP2E1 mRNA
CTD
PMID:27935865
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP2G1P
cytochrome P450 family 2 subfamily G member 1, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CYP2G1 mRNA
CTD
PMID:27935865
NCBI chr19:40,890,826...40,900,508
Ensembl chr19:40,891,219...40,900,155 Ensembl chr19:40,891,219...40,900,155
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
affects metabolic processing multiple interactions decreases activity increases expression
EXP ISO
CYP3A4 protein affects the metabolism of pioglitazone Pioglitazone inhibits the reaction [Endotoxins results in decreased expression of CYP3A2 protein] pioglitazone results in decreased activity of CYP3A4 protein Pioglitazone results in increased expression of CYP3A4 mRNA; Pioglitazone results in increased expression of CYP3A4 protein [pioglitazone results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl Estradiol; [pioglitazone results in increased expression of CYP3A4 protein] which results in decreased abundance of Midazolam; pioglitazone results in increased expression of and results in increased activity of CYP3A4 protein
CTD
PMID:12642470 PMID:15364003 PMID:15860655 PMID:15900286 PMID:16837568 PMID:22524704 PMID:31233785 More...
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions increases expression
ISO
pioglitazone promotes the reaction [U 0126 results in increased expression of CYP7A1 mRNA]; U 0126 promotes the reaction [pioglitazone results in increased expression of CYP7A1 mRNA]
CTD
PMID:22593575
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
DCAF12L1
DDB1 and CUL4 associated factor 12 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DCAF12L1 mRNA
CTD
PMID:27935865
NCBI chr X:126,549,383...126,552,814
Ensembl chr X:126,549,383...126,552,814
G
DCX
doublecortin
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCX protein]
CTD
PMID:32735850
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
G
DDAH1
dimethylarginine dimethylaminohydrolase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DDAH1 mRNA
CTD
PMID:27935865
NCBI chr 1:85,318,485...85,578,200
Ensembl chr 1:85,318,481...85,578,363
G
DDIT4
DNA damage inducible transcript 4
multiple interactions increases expression
EXP
[Metformin co-treated with Pioglitazone] results in increased expression of DDIT4 mRNA Pioglitazone results in increased expression of DDIT4 mRNA
CTD
PMID:32589349
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDIT4L
DNA damage inducible transcript 4 like
increases expression multiple interactions
EXP
Pioglitazone results in increased expression of DDIT4L mRNA [Metformin co-treated with Pioglitazone] results in increased expression of DDIT4L mRNA
CTD
PMID:32589349
NCBI chr 4:100,185,870...100,190,468
Ensembl chr 4:100,185,870...100,190,782
G
DEPP1
DEPP autophagy regulator 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]
CTD
PMID:20847119
NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
G
DEPTOR
DEP domain containing MTOR interacting protein
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of DEPTOR mRNA
CTD
PMID:32589349
NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918
G
DERL3
derlin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DERL3 mRNA
CTD
PMID:27935865
NCBI chr22:23,834,503...23,839,006
Ensembl chr22:23,834,503...23,839,128
G
DES
desmin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DES mRNA
CTD
PMID:27935865
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
G
DEUP1
deuterosome assembly protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DEUP1 mRNA
CTD
PMID:27935865
NCBI chr11:93,329,998...93,438,470
Ensembl chr11:93,329,971...93,438,487
G
DGAT1
diacylglycerol O-acyltransferase 1
increases expression
ISO
pioglitazone results in increased expression of DGAT1 mRNA
CTD
PMID:20723549
NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910
G
DGAT2
diacylglycerol O-acyltransferase 2
increases expression
ISO
pioglitazone results in increased expression of DGAT2 mRNA
CTD
PMID:20723549
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DHRS7C
dehydrogenase/reductase 7C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DHRS7C mRNA
CTD
PMID:27935865
NCBI chr17:9,771,438...9,791,592
Ensembl chr17:9,771,434...9,791,592
G
DIO2
iodothyronine deiodinase 2
increases activity increases expression multiple interactions
EXP ISO
pioglitazone results in increased activity of DIO2 protein pioglitazone results in increased expression of DIO2 mRNA PPARG protein promotes the reaction [pioglitazone results in increased activity of DIO2 protein]
CTD
PMID:19036883
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
G
DIO3
iodothyronine deiodinase 3
decreases activity
ISO
pioglitazone results in decreased activity of DIO3 protein
CTD
PMID:19036883
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
DLG1
discs large MAGUK scaffold protein 1
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
G
DMBT1
deleted in malignant brain tumors 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DMBT1 mRNA
CTD
PMID:27935865
NCBI chr10:122,560,754...122,643,736
Ensembl chr10:122,560,665...122,643,736
G
DNAAF2
dynein axonemal assembly factor 2
multiple interactions
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr14:49,625,174...49,635,244
Ensembl chr14:49,625,174...49,635,244
G
DNAH8
dynein axonemal heavy chain 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DNAH8 mRNA
CTD
PMID:27935865
NCBI chr 6:38,715,311...39,030,792
Ensembl chr 6:38,715,311...39,030,792
G
DNER
delta/notch like EGF repeat containing
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DNER mRNA
CTD
PMID:27935865
NCBI chr 2:229,357,629...229,714,555
Ensembl chr 2:229,357,629...229,714,555
G
DPT
dermatopontin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DPT mRNA
CTD
PMID:27935865
NCBI chr 1:168,695,468...168,729,206
Ensembl chr 1:168,695,468...168,729,206
G
DPY19L2
dpy-19 like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DPY19L2 mRNA
CTD
PMID:27935865
NCBI chr12:63,558,913...63,668,805
Ensembl chr12:63,558,913...63,668,939
G
DRD1
dopamine receptor D1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DRD1 mRNA
CTD
PMID:27935865
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DUSP10
dual specificity phosphatase 10
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA
CTD
PMID:20847119
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
G
DUSP26
dual specificity phosphatase 26
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of DUSP26 mRNA
CTD
PMID:27935865
NCBI chr 8:33,591,330...33,600,023
Ensembl chr 8:33,591,330...33,600,023
G
EDDM3B
epididymal protein 3B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EDDM3B mRNA
CTD
PMID:27935865
NCBI chr14:20,768,404...20,770,948
Ensembl chr14:20,768,404...20,770,948
G
EEF1A2
eukaryotic translation elongation factor 1 alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EEF1A2 mRNA
CTD
PMID:27935865
NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239
G
EGF
epidermal growth factor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EGF mRNA
CTD
PMID:27935865
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGFLAM
EGF like, fibronectin type III and laminin G domains
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EGFLAM mRNA
CTD
PMID:27935865
NCBI chr 5:38,258,559...38,465,480
Ensembl chr 5:38,258,409...38,465,480
G
EIF4E
eukaryotic translation initiation factor 4E
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of EIF4E mRNA
CTD
PMID:32589349
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions increases expression decreases phosphorylation
EXP
pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of EIF4EBP1 protein] Pioglitazone results in increased expression of EIF4EBP1 mRNA pioglitazone results in decreased phosphorylation of EIF4EBP1 protein
CTD
PMID:26643070 PMID:32589349
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
EIF4EBP2
eukaryotic translation initiation factor 4E binding protein 2
increases expression
EXP
Pioglitazone results in increased expression of EIF4EBP2 mRNA
CTD
PMID:32589349
NCBI chr10:70,404,145...70,428,618
Ensembl chr10:70,404,145...70,428,618
G
EIF5A
eukaryotic translation initiation factor 5A
increases expression
ISO
pioglitazone results in increased expression of EIF5A mRNA
CTD
PMID:21347706
NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463
G
ELOVL4
ELOVL fatty acid elongase 4
increases expression
EXP
Pioglitazone results in increased expression of ELOVL4 mRNA
CTD
PMID:30031879
NCBI chr 6:79,914,814...79,947,553
Ensembl chr 6:79,914,814...79,947,553
G
ENO3
enolase 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ENO3 mRNA
CTD
PMID:27935865
NCBI chr17:4,948,710...4,957,129
Ensembl chr17:4,948,092...4,957,131
G
EPGN
epithelial mitogen
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of EPGN mRNA
CTD
PMID:27935865
NCBI chr 4:74,308,470...74,316,789
Ensembl chr 4:74,308,470...74,316,789
G
EPHA3
EPH receptor A3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EPHA3 mRNA
CTD
PMID:27935865
NCBI chr 3:89,107,621...89,482,134
Ensembl chr 3:89,107,621...89,482,134
G
EPHA5
EPH receptor A5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EPHA5 mRNA
CTD
PMID:27935865
NCBI chr 4:65,319,567...65,670,489
Ensembl chr 4:65,319,563...65,670,495
G
EPYC
epiphycan
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EPYC mRNA
CTD
PMID:27935865
NCBI chr12:90,963,682...91,004,972
Ensembl chr12:90,963,682...91,005,026
G
ERBIN
erbb2 interacting protein
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 5:65,926,575...66,082,546
Ensembl chr 5:65,883,128...66,082,546
G
EREG
epiregulin
increases expression
EXP
Pioglitazone results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
G
ERVMER34-1
endogenous retrovirus group MER34 member 1, envelope
increases expression
EXP
Pioglitazone results in increased expression of ERVMER34-1 mRNA
CTD
PMID:30031879
NCBI chr 4:52,742,553...52,751,425
Ensembl chr 4:52,722,618...52,751,586
G
F10
coagulation factor X
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of F10 mRNA
CTD
PMID:27935865
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
FABP3
fatty acid binding protein 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FABP3 mRNA
CTD
PMID:27935865
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
G
FABP4
fatty acid binding protein 4
multiple interactions increases expression
EXP ISO
[pioglitazone co-treated with Tretinoin] results in increased expression of FABP4 mRNA Pioglitazone results in increased expression of FABP4 mRNA pioglitazone results in increased expression of FABP4 mRNA Pioglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]
CTD
PMID:9543393 PMID:12927809 PMID:15273253 PMID:16573735 PMID:17290005 PMID:19048458 PMID:30031879 PMID:32473317 More...
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
FAM13A
family with sequence similarity 13 member A
increases expression
EXP
Pioglitazone results in increased expression of FAM13A mRNA
CTD
PMID:30031879
NCBI chr 4:88,725,960...89,057,185
Ensembl chr 4:88,725,955...89,111,398
G
FAM171B
family with sequence similarity 171 member B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM171B mRNA
CTD
PMID:27935865
NCBI chr 2:186,694,060...186,765,959
Ensembl chr 2:186,694,060...186,765,959
G
FAM184B
family with sequence similarity 184 member B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM184B mRNA
CTD
PMID:27935865
NCBI chr 4:17,629,306...17,781,621
Ensembl chr 4:17,629,306...17,781,621
G
FAM210A
family with sequence similarity 210 member A
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA
CTD
PMID:20847119
NCBI chr18:13,663,347...13,726,558
Ensembl chr18:13,663,347...13,726,663
G
FAM240B
family with sequence similarity 240 member B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM240B mRNA
CTD
PMID:27935865
NCBI chr 9:38,694,266...38,720,133
Ensembl chr 9:38,694,266...38,720,133
G
FAM47E
family with sequence similarity 47 member E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM47E mRNA
CTD
PMID:27935865
NCBI chr 4:76,214,040...76,283,783
Ensembl chr 4:76,214,040...76,283,783
G
FAT4
FAT atypical cadherin 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAT4 mRNA
CTD
PMID:27935865
NCBI chr 4:125,314,955...125,492,932
Ensembl chr 4:125,314,918...125,492,932
G
FBLN1
fibulin 1
increases expression
EXP
Pioglitazone results in increased expression of FBLN1 mRNA
CTD
PMID:30031879
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBLN7
fibulin 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FBLN7 mRNA
CTD
PMID:27935865
NCBI chr 2:112,138,385...112,244,708
Ensembl chr 2:112,138,385...112,188,218
G
FBXL16
F-box and leucine rich repeat protein 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FBXL16 mRNA
CTD
PMID:27935865
NCBI chr16:692,500...705,801
Ensembl chr16:692,498...705,801
G
FBXO40
F-box protein 40
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FBXO40 mRNA
CTD
PMID:27935865
NCBI chr 3:121,593,379...121,630,295
Ensembl chr 3:121,593,379...121,630,295
G
FBXO43
F-box protein 43
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FBXO43 mRNA
CTD
PMID:27935865
NCBI chr 8:100,133,351...100,150,569
Ensembl chr 8:100,133,351...100,145,817
G
FCMR
Fc mu receptor
increases expression
EXP
Pioglitazone results in increased expression of FCMR mRNA
CTD
PMID:30031879
NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247
G
FGF21
fibroblast growth factor 21
increases expression
EXP ISO
pioglitazone results in increased expression of FGF21 mRNA
CTD
PMID:21720023
NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
G
FGF7
fibroblast growth factor 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FGF7 mRNA
CTD
PMID:27935865
NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775
G
FGL1
fibrinogen like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FGL1 mRNA
CTD
PMID:27935865
NCBI chr 8:17,864,389...17,895,538
Ensembl chr 8:17,864,380...17,910,365
G
FHL1
four and a half LIM domains 1
increases expression
EXP
Pioglitazone results in increased expression of FHL1 mRNA
CTD
PMID:30031879
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
G
FILIP1
filamin A interacting protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FILIP1 mRNA
CTD
PMID:27935865
NCBI chr 6:75,291,859...75,493,800
Ensembl chr 6:75,291,859...75,493,800
G
FJX1
four-jointed box kinase 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA
CTD
PMID:20847119
NCBI chr11:35,618,460...35,620,865
Ensembl chr11:35,618,460...35,620,865
G
FKBP1A
FKBP prolyl isomerase 1A
increases expression
EXP
Pioglitazone results in increased expression of FKBP1A mRNA
CTD
PMID:32589349
NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
G
FKBP8
FKBP prolyl isomerase 8
increases expression
EXP
Pioglitazone results in increased expression of FKBP8 mRNA
CTD
PMID:32589349
NCBI chr19:18,531,763...18,543,573
Ensembl chr19:18,531,751...18,544,077
G
FLNC
filamin C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FLNC mRNA
CTD
PMID:27935865
NCBI chr 7:128,830,406...128,859,272
Ensembl chr 7:128,830,406...128,859,274
G
FNDC5
fibronectin type III domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FNDC5 mRNA
CTD
PMID:27935865
NCBI chr 1:32,862,268...32,872,484
Ensembl chr 1:32,862,268...32,872,482
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
pioglitazone results in increased expression of FOS mRNA
CTD
PMID:11687581
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of FOSB mRNA
CTD
PMID:27935865
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of FOSL1 mRNA
CTD
PMID:27935865
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXN4
forkhead box N4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FOXN4 mRNA
CTD
PMID:27935865
NCBI chr12:109,277,978...109,309,284
Ensembl chr12:109,277,978...109,309,284
G
FPR1
formyl peptide receptor 1
decreases expression
EXP
Pioglitazone results in decreased expression of FPR1 mRNA
CTD
PMID:30031879
NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115
G
FRZB
frizzled related protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FRZB mRNA
CTD
PMID:27935865
NCBI chr 2:182,833,275...182,866,637
Ensembl chr 2:182,833,275...182,866,637
G
FSCN1
fascin actin-bundling protein 1
decreases expression
EXP
Pioglitazone results in decreased expression of FSCN1 mRNA
CTD
PMID:30031879
NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655
G
FSD2
fibronectin type III and SPRY domain containing 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FSD2 mRNA
CTD
PMID:27935865
NCBI chr15:82,755,362...82,806,069
Ensembl chr15:82,755,362...82,806,070
G
FXYD1
FXYD domain containing ion transport regulator 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FXYD1 mRNA
CTD
PMID:27935865
NCBI chr19:35,137,188...35,143,109
Ensembl chr19:35,138,824...35,143,109
G
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GABRA3 mRNA
CTD
PMID:27935865
NCBI chr X:152,166,234...152,451,315
Ensembl chr X:152,166,234...152,451,315
G
GABRA4
gamma-aminobutyric acid type A receptor subunit alpha4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GABRA4 mRNA
CTD
PMID:27935865
NCBI chr 4:46,918,900...46,993,581
Ensembl chr 4:46,918,900...46,993,581
G
GALNT16
polypeptide N-acetylgalactosaminyltransferase 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GALNT16 mRNA
CTD
PMID:27935865
NCBI chr14:69,259,631...69,386,337
Ensembl chr14:69,259,277...69,357,033
G
GALNT17
polypeptide N-acetylgalactosaminyltransferase 17
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of GALNT17 mRNA
CTD
PMID:27935865
NCBI chr 7:71,132,144...71,713,599
Ensembl chr 7:71,132,144...71,713,600
G
GALNT9
polypeptide N-acetylgalactosaminyltransferase 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GALNT9 mRNA
CTD
PMID:27935865
NCBI chr12:132,196,372...132,329,589
Ensembl chr12:132,196,372...132,329,589
G
GDF15
growth differentiation factor 15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GDF15 mRNA
CTD
PMID:27935865
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GEM
GTP binding protein overexpressed in skeletal muscle
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA
CTD
PMID:20847119
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
G
GEMIN4
gem nuclear organelle associated protein 4
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA
CTD
PMID:20847119
NCBI chr17:744,421...754,410
Ensembl chr17:744,421...753,999
G
GFRA1
GDNF family receptor alpha 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GFRA1 mRNA
CTD
PMID:27935865
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
GH1
growth hormone 1
increases expression
EXP
Pioglitazone results in increased expression of GH1 mRNA
CTD
PMID:30031879
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
G
GIMAP4
GTPase, IMAP family member 4
decreases expression
EXP
Pioglitazone results in decreased expression of GIMAP4 mRNA
CTD
PMID:30031879
NCBI chr 7:150,567,390...150,573,953
Ensembl chr 7:150,567,369...150,573,953
G
GLDN
gliomedin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GLDN mRNA
CTD
PMID:27935865
NCBI chr15:51,341,655...51,413,365
Ensembl chr15:51,341,655...51,408,005
G
GLYCAM1
glycosylation dependent cell adhesion molecule 1 (pseudogene)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GLYCAM1 mRNA
CTD
PMID:27935865
NCBI chr12:54,608,187...54,610,462
Ensembl chr12:54,608,187...54,610,462 Ensembl chr12:54,608,187...54,610,462
G
GMNC
geminin coiled-coil domain containing
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GMNC mRNA
CTD
PMID:27935865
NCBI chr 3:190,843,271...190,862,694
Ensembl chr 3:190,852,737...190,892,429
G
GNAT3
G protein subunit alpha transducin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GNAT3 mRNA
CTD
PMID:27935865
NCBI chr 7:80,458,635...80,512,064
Ensembl chr 7:80,458,635...80,512,064
G
GOT1
glutamic-oxaloacetic transaminase 1
multiple interactions
ISO
pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of GOT1 protein]
CTD
PMID:15318101
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GOT1L1
glutamic-oxaloacetic transaminase 1 like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GOT1L1 mRNA
CTD
PMID:27935865
NCBI chr 8:37,934,281...37,940,124
Ensembl chr 8:37,934,281...37,940,124
G
GP2
glycoprotein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GP2 mRNA
CTD
PMID:27935865
NCBI chr16:20,309,574...20,327,513
Ensembl chr16:20,309,574...20,327,808
G
GPIHBP1
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GPIHBP1 mRNA
CTD
PMID:27935865
NCBI chr 8:143,213,218...143,217,170
Ensembl chr 8:143,213,218...143,217,170
G
GPM6A
glycoprotein M6A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GPM6A mRNA
CTD
PMID:27935865
NCBI chr 4:175,632,937...176,002,691
Ensembl chr 4:175,632,934...176,002,664
G
GPR183
G protein-coupled receptor 183
decreases expression
EXP
Pioglitazone results in decreased expression of GPR183 mRNA
CTD
PMID:30031879
NCBI chr13:99,294,539...99,307,399
Ensembl chr13:99,294,539...99,307,399
G
GPR84
G protein-coupled receptor 84
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GPR84 mRNA
CTD
PMID:27935865
NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487
G
GPRASP2
G protein-coupled receptor associated sorting protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GPRASP2 mRNA
CTD
PMID:27935865
NCBI chr X:102,712,448...102,717,733
Ensembl chr X:102,712,445...102,717,733
G
GPT
glutamic--pyruvic transaminase
multiple interactions
ISO
pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of GPT protein]; pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased activity of GPT protein]
CTD
PMID:15318101 PMID:27350165
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX3
glutathione peroxidase 3
increases expression
EXP
Pioglitazone results in increased expression of GPX3 mRNA
CTD
PMID:30031879
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GRM4
glutamate metabotropic receptor 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GRM4 mRNA
CTD
PMID:27935865
NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
G
GSK3B
glycogen synthase kinase 3 beta
increases expression
EXP
Pioglitazone results in increased expression of GSK3B mRNA
CTD
PMID:32589349
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSTA2
glutathione S-transferase alpha 2
multiple interactions
ISO
[pioglitazone co-treated with alitretinoin] results in increased expression of GSTA2 protein
CTD
PMID:15150131
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTP1
glutathione S-transferase pi 1
multiple interactions
ISO
pioglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein]
CTD
PMID:15526359
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GSTT1 mRNA
CTD
PMID:27935865
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GUCY1A1 mRNA
CTD
PMID:27935865
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
G
HBB
hemoglobin subunit beta
multiple interactions
ISO
Pioglitazone inhibits the reaction [Fructose promotes the reaction [Glucose binds to HBB protein]]
CTD
PMID:25679220
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
G
HECW1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HECW1 mRNA
CTD
PMID:27935865
NCBI chr 7:43,112,647...43,566,001
Ensembl chr 7:43,112,629...43,566,001
G
HHATL
hedgehog acyltransferase like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HHATL mRNA
CTD
PMID:27935865
NCBI chr 3:42,692,663...42,702,798
Ensembl chr 3:42,692,663...42,702,824
G
HHIP
hedgehog interacting protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HHIP mRNA
CTD
PMID:27935865
NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271
G
HIF1A
hypoxia inducible factor 1 subunit alpha
decreases expression multiple interactions
EXP
Pioglitazone results in decreased expression of HIF1A mRNA [Metformin co-treated with Pioglitazone] results in decreased expression of HIF1A mRNA
CTD
PMID:32589349
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HIF3A
hypoxia inducible factor 3 subunit alpha
decreases expression
ISO
pioglitazone results in decreased expression of HIF3A mRNA
CTD
PMID:22456468
NCBI chr19:46,297,042...46,343,433
Ensembl chr19:46,297,042...46,343,433
G
HILPDA
hypoxia inducible lipid droplet associated
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
G
HJV
hemojuvelin BMP co-receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of HJV mRNA
CTD
PMID:27935865
NCBI chr 1:146,017,470...146,021,735
Ensembl chr 1:146,017,468...146,036,746
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression decreases expression
EXP ISO
pioglitazone results in increased expression of HMGCR mRNA pioglitazone results in decreased expression of HMGCR mRNA
CTD
PMID:12044893 PMID:20503262
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
pioglitazone results in increased expression of HMGCS1 mRNA
CTD
PMID:12044893
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HMOX1
heme oxygenase 1
increases expression multiple interactions
ISO EXP
pioglitazone results in increased expression of HMOX1 mRNA Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of HMOX1 mRNA]; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 mRNA] [pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA
CTD
PMID:16597547 PMID:28263783 PMID:30965670
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPDL
heterogeneous nuclear ribonucleoprotein D like
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]
CTD
PMID:20847119
NCBI chr 4:82,422,564...82,430,462
Ensembl chr 4:82,422,565...82,430,462
G
HPGD
15-hydroxyprostaglandin dehydrogenase
multiple interactions
EXP
[pioglitazone co-treated with NAD] binds to HPGD protein
CTD
PMID:25526675
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
G
HPSE2
heparanase 2 (inactive)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HPSE2 mRNA
CTD
PMID:27935865
NCBI chr10:98,457,077...99,315,951
Ensembl chr10:98,457,077...99,235,862
G
HRC
histidine rich calcium binding protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HRC mRNA
CTD
PMID:27935865
NCBI chr19:49,151,198...49,155,396
Ensembl chr19:49,151,198...49,155,396
G
HSD3B2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
decreases expression decreases activity
EXP
pioglitazone results in decreased expression of HSD3B2 mRNA pioglitazone results in decreased activity of HSD3B2 protein
CTD
PMID:15072549 PMID:17138841
NCBI chr 1:119,414,931...119,423,034
Ensembl chr 1:119,414,931...119,423,035
G
HSPA12B
heat shock protein family A (Hsp70) member 12B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HSPA12B mRNA
CTD
PMID:27935865
NCBI chr20:3,732,685...3,753,111
Ensembl chr20:3,732,685...3,753,111
G
HSPA1L
heat shock protein family A (Hsp70) member 1 like
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]
CTD
PMID:20847119
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
G
HSPB7
heat shock protein family B (small) member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of HSPB7 mRNA
CTD
PMID:27935865
NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,019,594
G
HTR2B
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of HTR2B mRNA
CTD
PMID:27935865
NCBI chr 2:231,108,230...231,125,042
Ensembl chr 2:231,108,230...231,125,042
G
ICAM1
intercellular adhesion molecule 1
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of ICAM1 protein]
CTD
PMID:17015710
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM3
intercellular adhesion molecule 3
multiple interactions
EXP
pioglitazone inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]
CTD
PMID:18158351
NCBI chr19:10,333,776...10,339,624
Ensembl chr19:10,333,776...10,339,661
G
ID2
inhibitor of DNA binding 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:20847119
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IFNG
interferon gamma
multiple interactions
EXP
pioglitazone inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein]; pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]
CTD
PMID:14586007
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF1
insulin like growth factor 1
multiple interactions decreases expression
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of IGF1 mRNA Pioglitazone results in decreased expression of IGF1 mRNA
CTD
PMID:32589349
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGSF10
immunoglobulin superfamily member 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of IGSF10 mRNA
CTD
PMID:27935865
NCBI chr 3:151,432,432...151,619,925
Ensembl chr 3:151,425,384...151,461,061
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
decreases expression
EXP
Pioglitazone results in decreased expression of IKBKB mRNA
CTD
PMID:32589349
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
G
IL10
interleukin 10
multiple interactions increases expression
ISO
Pioglitazone inhibits the reaction [propionic acid results in decreased expression of IL10 protein] Pioglitazone results in increased expression of IL10 protein
CTD
PMID:27918843 PMID:31348919
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL13 protein]
CTD
PMID:17015710
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL18
interleukin 18
multiple interactions
ISO
pioglitazone inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]
CTD
PMID:18660453
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
increases expression
EXP
Pioglitazone results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
multiple interactions increases expression affects expression
EXP ISO
Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein] [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; Fenofibrate promotes the reaction [Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]]; Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; Pioglitazone inhibits the reaction [Fructose results in increased secretion of IL1B protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of IL1B mRNA]; Pioglitazone promotes the reaction [Fenofibrate inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]] Pioglitazone results in increased expression of IL1B mRNA [pioglitazone co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA pioglitazone affects the expression of IL1B mRNA
CTD
PMID:14586007 PMID:25679220 PMID:28138970 PMID:30031879 PMID:30130594 PMID:32613381 PMID:32816093 PMID:36988379 More...
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL23A
interleukin 23 subunit alpha
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of IL23A mRNA
CTD
PMID:27935865
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL24
interleukin 24
multiple interactions increases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of IL24 mRNA Pioglitazone results in increased expression of IL24 mRNA
CTD
PMID:27935865 PMID:32816093
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
G
IL4
interleukin 4
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL4 protein]
CTD
PMID:17015710
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL5
interleukin 5
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL5 protein]
CTD
PMID:17015710
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL6
interleukin 6
multiple interactions increases expression affects expression
ISO
[Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of IL6 mRNA; [Sodium Glutamate co-treated with Pioglitazone] results in decreased expression of IL6 protein; Pioglitazone inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]; Pioglitazone promotes the reaction [Plant Extracts results in increased expression of IL6 protein] Pioglitazone results in increased expression of IL6 protein [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; Pioglitazone inhibits the reaction [propionic acid results in increased expression of IL6 protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of IL6 mRNA]; Pioglitazone inhibits the reaction [Streptozocin results in increased expression of IL6 protein] pioglitazone affects the expression of IL6 protein
CTD
PMID:18513333 PMID:27918843 PMID:28263783 PMID:28744220 PMID:29233026 PMID:30130594 PMID:31348919 PMID:37044004 More...
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ILK
integrin linked kinase
decreases expression
EXP
Pioglitazone results in decreased expression of ILK mRNA
CTD
PMID:32589349
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
G
INMT
indolethylamine N-methyltransferase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of INMT mRNA
CTD
PMID:27935865
NCBI chr 7:30,752,135...30,757,602
Ensembl chr 7:30,697,985...30,757,602
G
INS
insulin
multiple interactions
EXP ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; [Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein; octocrylene inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; T 0070907 inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]] [Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein; Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA]; Pioglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]; Pioglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mRNA]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]
CTD
PMID:15273253 PMID:17290005 PMID:31016361 PMID:32473317 PMID:32613381 PMID:34864131 More...
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions decreases secretion affects expression
EXP ISO
Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] Pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of INS1 protein]; Pioglitazone inhibits the reaction [Streptozocin results in increased expression of INS1 protein] Pioglitazone promotes the reaction [INS1 protein results in increased uptake of Glucose] Pioglitazone results in decreased secretion of INS1 protein Pioglitazone affects the expression of INS1 protein
CTD
PMID:14532171 PMID:19208898 PMID:27350165 PMID:28242381 PMID:29233026 PMID:32407875 PMID:37044004 More...
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
INSYN2B
inhibitory synaptic factor family member 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of INSYN2B mRNA
CTD
PMID:27935865
NCBI chr 5:169,861,303...169,980,495
Ensembl chr 5:169,861,303...169,980,495
G
IQCH
IQ motif containing H
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of IQCH mRNA
CTD
PMID:27935865
NCBI chr15:67,254,786...67,501,804
Ensembl chr15:67,254,786...67,502,260
G
IRAG1
inositol 1,4,5-triphosphate receptor associated 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of IRAG1 mRNA
CTD
PMID:27935865
NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988
G
ISL1
ISL LIM homeobox 1
increases expression
EXP
Pioglitazone results in increased expression of ISL1 mRNA
CTD
PMID:30031879
NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
G
ISM2
isthmin 2
increases expression
EXP
Pioglitazone results in increased expression of ISM2 mRNA
CTD
PMID:30031879
NCBI chr14:77,474,394...77,498,816
Ensembl chr14:77,474,394...77,498,816
G
ITGA8
integrin subunit alpha 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ITGA8 mRNA
CTD
PMID:27935865
NCBI chr10:15,513,954...15,719,922
Ensembl chr10:15,513,954...15,719,922
G
ITGAV
integrin subunit alpha V
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]
CTD
PMID:20847119
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
G
ITGB1BP2
integrin subunit beta 1 binding protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ITGB1BP2 mRNA
CTD
PMID:27935865
NCBI chr X:71,301,750...71,305,371
Ensembl chr X:71,301,750...71,305,371
G
ITIH2
inter-alpha-trypsin inhibitor heavy chain 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ITIH2 mRNA
CTD
PMID:27935865
NCBI chr10:7,703,316...7,749,520
Ensembl chr10:7,703,316...7,749,520
G
ITLN1
intelectin 1
increases expression
EXP
pioglitazone results in increased expression of ITLN1 protein
CTD
PMID:23555749
NCBI chr 1:160,876,540...160,885,180
Ensembl chr 1:160,876,540...160,885,180
G
JCHAIN
joining chain of multimeric IgA and IgM
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of JCHAIN mRNA
CTD
PMID:27935865
NCBI chr 4:70,655,541...70,666,508
Ensembl chr 4:70,655,541...70,681,817
G
JPH2
junctophilin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of JPH2 mRNA
CTD
PMID:27935865
NCBI chr20:44,106,590...44,187,188
Ensembl chr20:44,106,590...44,187,188
G
KANK4
KN motif and ankyrin repeat domains 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KANK4 mRNA
CTD
PMID:27935865
NCBI chr 1:62,236,165...62,319,434
Ensembl chr 1:62,236,165...62,319,434
G
KCNB1
potassium voltage-gated channel subfamily B member 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KCNB1 mRNA
CTD
PMID:27935865
NCBI chr20:49,363,877...49,483,362
Ensembl chr20:49,293,394...49,484,297
G
KCNC4
potassium voltage-gated channel subfamily C member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KCNC4 mRNA
CTD
PMID:27935865
NCBI chr 1:110,210,314...110,284,080
Ensembl chr 1:110,210,314...110,283,100
G
KCND3
potassium voltage-gated channel subfamily D member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KCND3 mRNA
CTD
PMID:27935865
NCBI chr 1:111,770,662...111,989,668
Ensembl chr 1:111,770,662...111,989,668
G
KCNJ11
potassium inwardly rectifying channel subfamily J member 11
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KCNJ11 mRNA
CTD
PMID:27935865
NCBI chr11:17,385,248...17,389,346
Ensembl chr11:17,365,172...17,389,331
G
KCNJ13
potassium inwardly rectifying channel subfamily J member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KCNJ13 mRNA
CTD
PMID:27935865
NCBI chr 2:232,765,802...232,776,565
Ensembl chr 2:232,765,802...232,776,565
G
KLF2
KLF transcription factor 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]
CTD
PMID:20847119
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
G
KLF5
KLF transcription factor 5
multiple interactions
ISO
pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 mRNA]; pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 protein]
CTD
PMID:25874449
NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
G
KLHL13
kelch like family member 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL13 mRNA
CTD
PMID:27935865
NCBI chr X:117,897,813...118,117,340
Ensembl chr X:117,897,813...118,117,340
G
KLHL31
kelch like family member 31
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL31 mRNA
CTD
PMID:27935865
NCBI chr 6:53,647,916...53,665,756
Ensembl chr 6:53,647,916...53,665,756
G
KLHL40
kelch like family member 40
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL40 mRNA
CTD
PMID:27935865
NCBI chr 3:42,685,537...42,692,544
Ensembl chr 3:42,685,537...42,692,544
G
KLHL41
kelch like family member 41
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL41 mRNA
CTD
PMID:27935865
NCBI chr 2:169,509,702...169,526,258
Ensembl chr 2:169,509,702...169,526,258
G
KLK6
kallikrein related peptidase 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of KLK6 mRNA
CTD
PMID:27935865
NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673
G
KRT16
keratin 16
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of KRT16 mRNA
CTD
PMID:27935865
NCBI chr17:41,609,778...41,612,767
Ensembl chr17:41,609,778...41,615,899
G
KRT20
keratin 20
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of KRT20 mRNA
CTD
PMID:27935865
NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,875,889...40,885,242
G
KRT6A
keratin 6A
decreases expression
EXP
Pioglitazone results in decreased expression of KRT6A mRNA
CTD
PMID:30031879
NCBI chr12:52,487,176...52,493,257
Ensembl chr12:52,487,176...52,493,257
G
KRT6B
keratin 6B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of KRT6B mRNA
CTD
PMID:27935865
NCBI chr12:52,446,651...52,452,146
Ensembl chr12:52,446,651...52,452,146
G
KRT84
keratin 84
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of KRT84 mRNA
CTD
PMID:27935865
NCBI chr12:52,377,812...52,386,977
Ensembl chr12:52,377,812...52,385,652
G
KRT90P
keratin 90, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of KRT90 mRNA
CTD
PMID:27935865
NCBI chr12:52,413,861...52,419,240
Ensembl chr12:52,411,742...52,421,867
G
KY
kyphoscoliosis peptidase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KY mRNA
CTD
PMID:27935865
NCBI chr 3:134,599,923...134,651,022
Ensembl chr 3:134,599,923...134,651,636
G
LAMA2
laminin subunit alpha 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LAMA2 mRNA
CTD
PMID:27935865
NCBI chr 6:128,883,138...129,516,566
Ensembl chr 6:128,883,138...129,516,566
G
LARP6
La ribonucleoprotein 6, translational regulator
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LARP6 mRNA
CTD
PMID:27935865
NCBI chr15:70,829,130...70,854,157
Ensembl chr15:70,829,130...70,854,157
G
LCE1F
late cornified envelope 1F
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of LCE1F mRNA
CTD
PMID:27935865
NCBI chr 1:152,775,140...152,777,024
Ensembl chr 1:152,775,140...152,777,024
G
LDLR
low density lipoprotein receptor
increases expression multiple interactions
ISO
pioglitazone results in increased expression of LDLR protein [pioglitazone co-treated with U 0126] affects the localization of LDLR protein
CTD
PMID:22593575
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEP
leptin
increases expression
ISO
pioglitazone results in increased expression of LEP protein
CTD
PMID:15655531
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LEPR
leptin receptor
increases response to substance multiple interactions
ISO
LEPR gene mutant form results in increased susceptibility to Pioglitazone Pioglitazone inhibits the reaction [LEPR protein affects the expression of OGG1 protein]; Pioglitazone inhibits the reaction [LEPR protein affects the expression of XRCC1 protein]
CTD
PMID:29743445 PMID:35472412
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LGI1
leucine rich glioma inactivated 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LGI1 mRNA
CTD
PMID:27935865
NCBI chr10:93,757,936...93,798,159
Ensembl chr10:93,757,840...93,806,272
G
LHFPL4
LHFPL tetraspan subfamily member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LHFPL4 mRNA
CTD
PMID:27935865
NCBI chr 3:9,498,361...9,553,822
Ensembl chr 3:9,498,361...9,553,822
G
LILRA2
leukocyte immunoglobulin like receptor A2
decreases expression
EXP
Pioglitazone results in decreased expression of LILRA2 mRNA
CTD
PMID:30031879
NCBI chr19:54,572,988...54,590,287
Ensembl chr19:54,572,920...54,590,287
G
LIPC
lipase C, hepatic type
increases expression
ISO
pioglitazone results in increased expression of LIPC mRNA
CTD
PMID:20503262
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LIPF
lipase F, gastric type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LIPF mRNA
CTD
PMID:27935865
NCBI chr10:88,664,442...88,678,814
Ensembl chr10:88,664,441...88,678,814
G
LIPN
lipase family member N
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of LIPN mRNA
CTD
PMID:27935865
NCBI chr10:88,757,226...88,779,626
Ensembl chr10:88,759,982...88,779,626
G
LITAF
lipopolysaccharide induced TNF factor
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
LMAN1L
lectin, mannose binding 1 like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LMAN1L mRNA
CTD
PMID:27935865
NCBI chr15:74,812,835...74,825,754
Ensembl chr15:74,812,716...74,825,757
G
LMOD3
leiomodin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LMOD3 mRNA
CTD
PMID:27935865
NCBI chr 3:69,106,065...69,122,595
Ensembl chr 3:69,106,065...69,123,032
G
LRRC39
leucine rich repeat containing 39
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LRRC39 mRNA
CTD
PMID:27935865
NCBI chr 1:100,148,448...100,179,667
Ensembl chr 1:100,148,448...100,178,267
G
LRRC3B
leucine rich repeat containing 3B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LRRC3B mRNA
CTD
PMID:27935865
NCBI chr 3:26,622,772...26,710,776
Ensembl chr 3:26,622,772...26,717,537
G
LRRN1
leucine rich repeat neuronal 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LRRN1 mRNA
CTD
PMID:27935865
NCBI chr 3:3,799,431...3,849,834
Ensembl chr 3:3,799,431...3,849,834
G
LRRN3
leucine rich repeat neuronal 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of LRRN3 mRNA
CTD
PMID:27935865
NCBI chr 7:111,091,127...111,125,454
Ensembl chr 7:111,091,006...111,125,454
G
MAGIX
MAGI family member, X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MAGIX mRNA
CTD
PMID:27935865
NCBI chr X:49,162,665...49,168,774
Ensembl chr X:49,162,564...49,168,774
G
MAOB
monoamine oxidase B
multiple interactions
EXP
pioglitazone binds to and results in decreased activity of MAOB protein
CTD
PMID:22282722
NCBI chr X:43,766,610...43,882,450
Ensembl chr X:43,766,610...43,882,450
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions decreases phosphorylation
ISO EXP
pioglitazone inhibits the reaction [Streptozocin results in increased expression of MAPK1 mRNA]; pioglitazone inhibits the reaction [Streptozocin results in increased expression of MAPK1 protein]; pioglitazone results in increased phosphorylation of and results in increased activity of MAPK1 protein pioglitazone results in decreased phosphorylation of MAPK1 protein [PDGFB protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:11687581 PMID:17063547 PMID:26643070
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions decreases phosphorylation
ISO EXP
pioglitazone results in increased phosphorylation of and results in increased activity of MAPK3 protein [PDGFB protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:11687581 PMID:26643070
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MB
myoglobin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MB mRNA
CTD
PMID:27935865
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
G
MB21D2
Mab-21 domain containing 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA
CTD
PMID:20847119
NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856
G
MCEMP1
mast cell expressed membrane protein 1
increases expression
EXP
Pioglitazone results in increased expression of MCEMP1 mRNA
CTD
PMID:30031879
NCBI chr19:7,677,090...7,679,829
Ensembl chr19:7,677,088...7,679,829
G
MCIDAS
multiciliate differentiation and DNA synthesis associated cell cycle protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MCIDAS mRNA
CTD
PMID:27935865
NCBI chr 5:55,219,564...55,227,315
Ensembl chr 5:55,219,564...55,227,315
G
MEF2C
myocyte enhancer factor 2C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MEF2C mRNA
CTD
PMID:27935865
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
G
MET
MET proto-oncogene, receptor tyrosine kinase
increases expression
EXP
Pioglitazone results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
METTL21EP
methyltransferase like 21E, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of METTL21E mRNA
CTD
PMID:27935865
NCBI chr13:102,880,099...102,896,033
Ensembl chr13:102,880,040...102,896,033
G
MFAP4
microfibril associated protein 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MFAP4 mRNA
CTD
PMID:27935865
NCBI chr17:19,383,445...19,387,190
Ensembl chr17:19,383,442...19,387,190
G
MGAM
maltase-glucoamylase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MGAM mRNA
CTD
PMID:27935865
NCBI chr 7:141,986,518...142,106,747
Ensembl chr 7:141,907,813...142,106,747
G
MIR133B
microRNA 133b
multiple interactions
ISO
[Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of MIR133B mRNA
CTD
PMID:28263783
NCBI chr 6:52,148,923...52,149,041
Ensembl chr 6:52,148,923...52,149,041
G
MIR206
microRNA 206
multiple interactions
ISO
[Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of MIR206 mRNA
CTD
PMID:28263783
NCBI chr 6:52,144,349...52,144,434
Ensembl chr 6:52,144,349...52,144,434
G
MLIP
muscular LMNA interacting protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MLIP mRNA
CTD
PMID:27935865
NCBI chr 6:54,018,970...54,266,280
Ensembl chr 6:53,929,982...54,266,280
G
MME
membrane metalloendopeptidase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MME mRNA
CTD
PMID:27935865
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP12
matrix metallopeptidase 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MMP12 mRNA
CTD
PMID:27935865
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP13
matrix metallopeptidase 13
multiple interactions
ISO
pioglitazone affects the reaction [Carbon Tetrachloride results in increased cleavage of MMP13 protein]
CTD
PMID:16484506
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP7
matrix metallopeptidase 7
multiple interactions decreases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MMP7 mRNA Pioglitazone results in decreased expression of MMP7 mRNA
CTD
PMID:27935865 PMID:30031879
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MMP8
matrix metallopeptidase 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MMP8 mRNA
CTD
PMID:27935865
NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
G
MMP9
matrix metallopeptidase 9
multiple interactions decreases expression decreases secretion
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]; pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] Pioglitazone results in decreased expression of MMP9 mRNA pioglitazone results in decreased secretion of MMP9 protein
CTD
PMID:16860414 PMID:17055343 PMID:30031879
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MS4A7
membrane spanning 4-domains A7
increases expression
EXP
Pioglitazone results in increased expression of MS4A7 mRNA
CTD
PMID:30031879
NCBI chr11:60,378,532...60,395,948
Ensembl chr11:60,378,485...60,395,951
G
MSTN
myostatin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MSTN mRNA
CTD
PMID:27935865
NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
G
MTARC1
mitochondrial amidoxime reducing component 1
increases expression
EXP
Pioglitazone results in increased expression of MTARC1 mRNA
CTD
PMID:30031879
NCBI chr 1:220,786,913...220,819,659
Ensembl chr 1:220,786,352...220,819,659
G
MTOR
mechanistic target of rapamycin kinase
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of MTOR mRNA
CTD
PMID:32589349
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MUC1
mucin 1, cell surface associated
decreases expression
EXP
Pioglitazone results in decreased expression of MUC1 mRNA
CTD
PMID:30031879
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MUC5B mRNA
CTD
PMID:27935865
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
MUCL3
mucin like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of MUCL3 mRNA
CTD
PMID:27935865
NCBI chr 6:30,940,973...30,954,221
Ensembl chr 6:30,934,523...30,954,221
G
MXD1
MAX dimerization protein 1
multiple interactions
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MYBPC1
myosin binding protein C1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYBPC1 mRNA
CTD
PMID:27935865
NCBI chr12:101,594,971...101,695,841
Ensembl chr12:101,568,353...101,686,028
G
MYF6
myogenic factor 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYF6 mRNA
CTD
PMID:27935865
NCBI chr12:80,707,634...80,709,474
Ensembl chr12:80,707,634...80,709,474
G
MYH1
myosin heavy chain 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYH1 mRNA
CTD
PMID:27935865
NCBI chr17:10,492,307...10,518,542
Ensembl chr17:10,492,307...10,518,542
G
MYH11
myosin heavy chain 11
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYH11 mRNA
CTD
PMID:27935865
NCBI chr16:15,703,135...15,857,028
Ensembl chr16:15,703,135...15,857,028
G
MYH13
myosin heavy chain 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYH13 mRNA
CTD
PMID:27935865
NCBI chr17:10,300,865...10,373,006
Ensembl chr17:10,300,865...10,373,130
G
MYH2
myosin heavy chain 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYH2 mRNA
CTD
PMID:27935865
NCBI chr17:10,521,148...10,549,658
Ensembl chr17:10,521,148...10,549,700
G
MYH4
myosin heavy chain 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYH4 mRNA
CTD
PMID:27935865
NCBI chr17:10,443,263...10,469,559
Ensembl chr17:10,443,290...10,469,559
G
MYL1
myosin light chain 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYL1 mRNA
CTD
PMID:27935865
NCBI chr 2:210,290,150...210,315,174
Ensembl chr 2:210,290,150...210,315,174
G
MYL11
myosin light chain 11
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of MYLPF mRNA
CTD
PMID:27935865
NCBI chr16:30,370,934...30,377,991
Ensembl chr16:30,370,934...30,377,991
G
MYL9
myosin light chain 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYL9 mRNA
CTD
PMID:27935865
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
G
MYLK
myosin light chain kinase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYLK mRNA
CTD
PMID:27935865
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
MYO18B
myosin XVIIIB
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYO18B mRNA
CTD
PMID:27935865
NCBI chr22:25,742,188...26,063,847
Ensembl chr22:25,742,144...26,031,045
G
MYO1C
myosin IC
increases expression
EXP
Pioglitazone results in increased expression of MYO1C mRNA
CTD
PMID:32589349
NCBI chr17:1,464,186...1,492,686
Ensembl chr17:1,464,186...1,492,686
G
MYOM1
myomesin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOM1 mRNA
CTD
PMID:27935865
NCBI chr18:3,066,807...3,247,376
Ensembl chr18:3,066,807...3,219,968
G
MYOM2
myomesin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOM2 mRNA
CTD
PMID:27935865
NCBI chr 8:2,045,046...2,145,456
Ensembl chr 8:2,045,046...2,165,552
G
MYOM3
myomesin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOM3 mRNA
CTD
PMID:27935865
NCBI chr 1:24,056,041...24,112,135
Ensembl chr 1:24,056,035...24,112,135
G
MYOT
myotilin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOT mRNA
CTD
PMID:27935865
NCBI chr 5:137,867,860...137,887,851
Ensembl chr 5:137,867,858...137,887,851
G
MYOZ1
myozenin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOZ1 mRNA
CTD
PMID:27935865
NCBI chr10:73,631,612...73,641,474
Ensembl chr10:73,631,612...73,641,474
G
MYOZ3
myozenin 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYOZ3 mRNA
CTD
PMID:27935865
NCBI chr 5:150,660,869...150,679,368
Ensembl chr 5:150,660,882...150,679,368
G
MYPN
myopalladin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MYPN mRNA
CTD
PMID:27935865
NCBI chr10:68,087,897...68,212,017
Ensembl chr10:68,087,897...68,212,017
G
MZB1
marginal zone B and B1 cell specific protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MZB1 mRNA
CTD
PMID:27935865
NCBI chr 5:139,387,467...139,389,913
Ensembl chr 5:139,387,467...139,390,081
G
NAALAD2
N-acetylated alpha-linked acidic dipeptidase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NAALAD2 mRNA
CTD
PMID:27935865
NCBI chr11:90,131,699...90,192,894
Ensembl chr11:90,131,515...90,192,894
G
NDRG1
N-myc downstream regulated 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA
CTD
PMID:20847119
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NEB
nebulin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NEB mRNA
CTD
PMID:27935865
NCBI chr 2:151,485,339...151,734,476
Ensembl chr 2:151,485,336...151,734,487
G
NEGR1
neuronal growth regulator 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NEGR1 mRNA
CTD
PMID:27935865
NCBI chr 1:71,395,943...72,282,539
Ensembl chr 1:71,395,943...72,282,539
G
NEXN
nexilin F-actin binding protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NEXN mRNA
CTD
PMID:27935865
NCBI chr 1:77,888,624...77,943,895
Ensembl chr 1:77,888,513...77,943,895
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 mRNA]]; NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 protein]]; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 mRNA]; Pioglitazone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 mRNA]
CTD
PMID:30965670
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKBIB
NFKB inhibitor beta
multiple interactions
EXP
pioglitazone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein]
CTD
PMID:17055343
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NKAIN3
sodium/potassium transporting ATPase interacting 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NKAIN3 mRNA
CTD
PMID:27935865
NCBI chr 8:62,248,854...62,999,652
Ensembl chr 8:62,248,591...63,014,000
G
NKX3-1
NK3 homeobox 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NKX3-1 mRNA
CTD
PMID:27935865
NCBI chr 8:23,678,693...23,682,938
Ensembl chr 8:23,678,697...23,682,938
G
NMRK2
nicotinamide riboside kinase 2
decreases expression
EXP
Pioglitazone results in decreased expression of NMRK2 mRNA
CTD
PMID:30031879
NCBI chr19:3,933,069...3,942,416
Ensembl chr19:3,933,069...3,942,416
G
NOS2
nitric oxide synthase 2
decreases expression affects expression multiple interactions
ISO EXP
pioglitazone results in decreased expression of NOS2 mRNA pioglitazone affects the expression of NOS2 Pioglitazone inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of NOS2 protein]; Pioglitazone inhibits the reaction [Endotoxins results in increased expression of NOS2 protein] pioglitazone inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter]
CTD
PMID:15364003 PMID:15817521 PMID:17492134 PMID:21962020 PMID:30343038
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of NOS3 protein]
CTD
PMID:30343038
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NOX1
NADPH oxidase 1
affects activity
ISO
pioglitazone affects the activity of NOX1 protein
CTD
PMID:21962020
NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359
G
NOX4
NADPH oxidase 4
multiple interactions
ISO
pioglitazone inhibits the reaction [Streptozocin results in increased expression of NOX4 mRNA]
CTD
PMID:16979161
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NPHS1
NPHS1 adhesion molecule, nephrin
increases expression multiple interactions
EXP
Pioglitazone results in increased expression of NPHS1 mRNA 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Pioglitazone results in increased expression of NPHS1 mRNA]; Pioglitazone promotes the reaction [PPARG protein binds to NPHS1 promoter]
CTD
PMID:16687628
NCBI chr19:35,825,372...35,852,504
Ensembl chr19:35,825,372...35,869,287
G
NPPB
natriuretic peptide B
decreases expression
EXP
Pioglitazone results in decreased expression of NPPB mRNA
CTD
PMID:30031879
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NPY
neuropeptide Y
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of NPY mRNA
CTD
PMID:27935865
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
G
NPY1R
neuropeptide Y receptor Y1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NPY1R mRNA
CTD
PMID:27935865
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 mRNA]]; NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 protein]]; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 mRNA]; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 protein]; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of NQO1 mRNA]
CTD
PMID:30965670
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1H2
nuclear receptor subfamily 1 group H member 2
increases expression
EXP
pioglitazone results in increased expression of NR1H2 mRNA
CTD
PMID:19201410
NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
G
NR1H3
nuclear receptor subfamily 1 group H member 3
multiple interactions increases expression affects response to substance
EXP ISO
22-hydroxycholesterol promotes the reaction [pioglitazone results in increased expression of NR1H3 mRNA]; NR1H3 protein affects the reaction [pioglitazone results in increased expression of PPARA mRNA] NR1H3 protein affects the susceptibility to pioglitazone
CTD
PMID:15381068 PMID:19201410
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR1I2
nuclear receptor subfamily 1 group I member 2
affects localization
EXP
Pioglitazone affects the localization of NR1I2 protein
CTD
PMID:31233785
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR4A1
nuclear receptor subfamily 4 group A member 1
increases expression
ISO
pioglitazone results in increased expression of NR4A1 mRNA
CTD
PMID:17785466
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
G
NR4A3
nuclear receptor subfamily 4 group A member 3
increases expression
ISO
pioglitazone results in increased expression of NR4A3 mRNA
CTD
PMID:17785466
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
G
NRAP
nebulin related anchoring protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NRAP mRNA
CTD
PMID:27935865
NCBI chr10:113,588,714...113,664,041
Ensembl chr10:113,588,714...113,664,070
G
NSG2
neuronal vesicle trafficking associated 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NSG2 mRNA
CTD
PMID:27935865
NCBI chr 5:174,045,706...174,109,179
Ensembl chr 5:174,045,706...174,243,501
G
NUCB2
nucleobindin 2
increases stability
EXP
pioglitazone results in increased stability of NUCB2 mRNA
CTD
PMID:20427483
NCBI chr11:17,276,739...17,349,980
Ensembl chr11:17,208,153...17,349,980
G
OBSCN
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OBSCN mRNA
CTD
PMID:27935865
NCBI chr 1:228,208,044...228,378,876
Ensembl chr 1:228,208,044...228,378,876
G
OGG1
8-oxoguanine DNA glycosylase
multiple interactions
ISO
Pioglitazone inhibits the reaction [LEPR protein affects the expression of OGG1 protein]
CTD
PMID:35472412
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
G
OLFML1
olfactomedin like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OLFML1 mRNA
CTD
PMID:27935865
NCBI chr11:7,485,506...7,511,377
Ensembl chr11:7,485,388...7,511,377
G
OPCML
opioid binding protein/cell adhesion molecule like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OPCML mRNA
CTD
PMID:27935865
NCBI chr11:132,414,981...133,532,501
Ensembl chr11:132,414,977...133,532,501
G
OPTC
opticin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OPTC mRNA
CTD
PMID:27935865
NCBI chr 1:203,494,153...203,508,949
Ensembl chr 1:203,494,153...203,508,949
G
PAX1
paired box 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PAX1 mRNA
CTD
PMID:27935865
NCBI chr20:21,705,664...21,718,481
Ensembl chr20:21,705,659...21,718,481
G
PCDH18
protocadherin 18
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PCDH18 mRNA
CTD
PMID:27935865
NCBI chr 4:137,518,918...137,532,494
Ensembl chr 4:137,518,918...137,532,494
G
PCK1
phosphoenolpyruvate carboxykinase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PCK1 mRNA
CTD
PMID:27935865
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
G
PCLO
piccolo presynaptic cytomatrix protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PCLO mRNA
CTD
PMID:27935865
NCBI chr 7:82,754,012...83,162,884
Ensembl chr 7:82,754,012...83,162,930
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
increases expression
EXP
Pioglitazone results in increased expression of PCOLCE2 mRNA
CTD
PMID:30031879
NCBI chr 3:142,817,874...142,889,083
Ensembl chr 3:142,815,922...142,889,206
G
PCSK9
proprotein convertase subtilisin/kexin type 9
multiple interactions increases expression
EXP ISO
pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA] pioglitazone results in increased expression of PCSK9 protein [pioglitazone co-treated with U 0126] results in increased secretion of PCSK9 protein pioglitazone results in increased expression of PCSK9 mRNA; pioglitazone results in increased expression of PCSK9 protein
CTD
PMID:22593575
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,447...55,064,852
G
PDE6C
phosphodiesterase 6C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PDE6C mRNA
CTD
PMID:27935865
NCBI chr10:93,612,537...93,666,010
Ensembl chr10:93,612,537...93,666,010
G
PDGFB
platelet derived growth factor subunit B
multiple interactions
EXP
[PDGFB protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK1 protein]; [PDGFB protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK3 protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CCND1 protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CDKN1A protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of EIF4EBP1 protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]; pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6KB1 protein]; PRKAA1 protein affects the reaction [pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]]
CTD
PMID:26643070
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFRA
platelet derived growth factor receptor alpha
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PDGFRA mRNA
CTD
PMID:27935865
NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245
G
PDK4
pyruvate dehydrogenase kinase 4
increases expression
EXP
Pioglitazone results in increased expression of PDK4 mRNA
CTD
PMID:30031879
NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
G
PEG10
paternally expressed 10
increases expression
EXP
Pioglitazone results in increased expression of PEG10 mRNA
CTD
PMID:30031879
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PERM1
PPARGC1 and ESRR induced regulator, muscle 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PERM1 mRNA
CTD
PMID:27935865
NCBI chr 1:975,198...982,093
Ensembl chr 1:975,198...982,117
G
PGAM2
phosphoglycerate mutase 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PGAM2 mRNA
CTD
PMID:27935865
NCBI chr 7:44,062,727...44,065,567
Ensembl chr 7:44,062,727...44,065,567
G
PGM5
phosphoglucomutase 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PGM5 mRNA
CTD
PMID:27935865
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PHACTR1
phosphatase and actin regulator 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PHACTR1 mRNA
CTD
PMID:27935865
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PHETA2
PH domain containing endocytic trafficking adaptor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PHETA2 mRNA
CTD
PMID:27935865
NCBI chr22:42,074,248...42,079,438
Ensembl chr22:42,074,248...42,079,438
G
PHEX
phosphate regulating endopeptidase X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PHEX mRNA
CTD
PMID:27935865
NCBI chr X:22,032,325...22,251,310
Ensembl chr X:22,032,325...22,494,713
G
PHGR1
proline, histidine and glycine rich 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of PHGR1 mRNA
CTD
PMID:27935865
NCBI chr15:40,351,033...40,356,434
Ensembl chr15:40,351,033...40,356,434
G
PID1
phosphotyrosine interaction domain containing 1
increases expression
EXP
Pioglitazone results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 2:229,023,973...229,271,287
Ensembl chr 2:228,850,526...229,271,287
G
PIEZO2
piezo type mechanosensitive ion channel component 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PIEZO2 mRNA
CTD
PMID:27935865
NCBI chr18:10,670,247...11,149,569
Ensembl chr18:10,666,483...11,149,569
G
PIK3C3
phosphatidylinositol 3-kinase catalytic subunit type 3
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3C3 mRNA
CTD
PMID:32589349
NCBI chr18:41,955,234...42,087,830
Ensembl chr18:41,955,234...42,087,830
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
multiple interactions decreases expression
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3CA mRNA Pioglitazone results in decreased expression of PIK3CA mRNA
CTD
PMID:32589349
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3CB mRNA
CTD
PMID:32589349
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,698...138,834,928
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3CG mRNA
CTD
PMID:32589349
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PKNOX2
PBX/knotted 1 homeobox 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PKNOX2 mRNA
CTD
PMID:27935865
NCBI chr11:125,164,751...125,433,389
Ensembl chr11:125,164,687...125,433,389
G
PLAAT1
phospholipase A and acyltransferase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of PLAAT1 mRNA
CTD
PMID:27935865
NCBI chr 3:193,240,606...193,281,426
Ensembl chr 3:193,241,128...193,277,738
G
PLD1
phospholipase D1
multiple interactions decreases expression
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of PLD1 mRNA Pioglitazone results in decreased expression of PLD1 mRNA
CTD
PMID:32589349
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
G
PLEK
pleckstrin
decreases expression
EXP
Pioglitazone results in decreased expression of PLEK mRNA
CTD
PMID:30031879
NCBI chr 2:68,365,282...68,397,453
Ensembl chr 2:68,365,282...68,397,453
G
PLIN1
perilipin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of PLIN1 mRNA; Pioglitazone promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mRNA]
CTD
PMID:27935865 PMID:32473317
NCBI chr15:89,664,367...89,679,367
Ensembl chr15:89,664,367...89,679,427
G
PLIN2
perilipin 2
increases expression
EXP
Pioglitazone results in increased expression of PLIN2 mRNA
CTD
PMID:15381068 PMID:30031879
NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290
G
PLIN4
perilipin 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PLIN4 mRNA
CTD
PMID:27935865
NCBI chr19:4,502,192...4,518,486
Ensembl chr19:4,502,192...4,518,486
G
PLN
phospholamban
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PLN mRNA
CTD
PMID:27935865
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
PNMA8B
PNMA family member 8B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of PNMA8B mRNA
CTD
PMID:27935865
NCBI chr19:46,491,191...46,495,867
Ensembl chr19:46,486,906...46,495,879
G
POR
cytochrome p450 oxidoreductase
increases expression
ISO
pioglitazone results in increased expression of POR mRNA
CTD
PMID:16597547
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
PPARA
peroxisome proliferator activated receptor alpha
multiple interactions increases activity affects binding increases expression affects response to substance
ISO EXP
pioglitazone binds to and results in increased activity of PPARA protein pioglitazone results in increased activity of PPARA protein pioglitazone binds to PPARA protein pioglitazone results in increased expression of PPARA mRNA PPARA protein affects the susceptibility to pioglitazone pioglitazone results in increased expression of PPARA mRNA; pioglitazone results in increased expression of PPARA protein NR1H3 protein affects the reaction [pioglitazone results in increased expression of PPARA mRNA]; pioglitazone results in increased activity of [PPARA protein binds to RXRA protein]
CTD
PMID:11172467 PMID:11779144 PMID:15273253 PMID:16751799 PMID:19201410 PMID:23150725 PMID:23843199 More...
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARD
peroxisome proliferator activated receptor delta
affects binding increases expression increases activity multiple interactions
EXP ISO
pioglitazone binds to PPARB protein; pioglitazone binds to PPARD protein pioglitazone results in increased expression of PPARD mRNA pioglitazone results in increased activity of PPARD protein pioglitazone results in increased activity of [PPARD protein binds to RXRA protein]
CTD
PMID:11779144 PMID:19201410 PMID:23150725 PMID:23843199
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions affects expression increases activity affects binding increases expression affects response to substance
EXP ISO
[Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein; Ethanol inhibits the reaction [Pioglitazone results in increased activity of PPARG protein]; GW 1929 inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]; luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein]; Melatonin promotes the reaction [Pioglitazone results in increased expression of PPARG protein]; Pioglitazone binds to and results in increased activity of PPARG protein; Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein]; Pioglitazone inhibits the reaction [GW 1929 binds to PPARG protein]; Pioglitazone promotes the reaction [Melatonin results in increased expression of PPARG protein]; Pioglitazone promotes the reaction [PPARG protein binds to NPHS1 promoter]; Pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA]; Pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein]; PPARG protein affects the reaction [Pioglitazone results in increased expression of CD36 protein]; PPARG protein promotes the reaction [Pioglitazone results in increased activity of DIO2 protein]; Ro 41-5253 inhibits the reaction [Pioglitazone results in increased activity of PPARG protein] pioglitazone affects the expression of PPARG mRNA; pioglitazone affects the expression of PPARG protein Pioglitazone binds to PPARG protein pioglitazone results in increased expression of PPARG mRNA Pioglitazone results in increased expression of PPARG mRNA; Pioglitazone results in increased expression of PPARG mRNA alternative form; Pioglitazone results in increased expression of PPARG protein pioglitazone results in increased activity of PPARG protein PPARG protein affects the susceptibility to pioglitazone 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG protein]; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]; [Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]; [Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Phospholipids]; [Pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides]; [Pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides; [Pioglitazone results in increased activity of PPARG protein] which results in increased abundance of Diglycerides; Pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein]; Pioglitazone binds to and results in increased activity of PPARG protein; Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Fructose results in decreased activity of PPARG protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]; T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA]; T 0070907 inhibits the reaction [Pioglitazone affects the expression of PPARG protein] pioglitazone affects the expression of PPARG; pioglitazone affects the expression of PPARG mRNA [ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein]; [Dexamethasone co-treated with INS protein co-treated with pioglitazone] results in increased expression of PPARG protein; [pioglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of RETSAT mRNA; [pioglitazone co-treated with alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]; pioglitazone binds to and results in increased activity of PPARG protein; pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]; pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron]; pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]; pioglitazone results in increased activity of and results in decreased expression of PPARG protein; PPARG protein affects the reaction [pioglitazone results in increased expression of ADIPOQ mRNA]
CTD
PMID:9836514 PMID:11172467 PMID:11779144 PMID:11991651 PMID:12055599 PMID:12927809 PMID:15150131 PMID:15273253 PMID:15318101 PMID:15729575 PMID:15992368 PMID:16007095 PMID:16324916 PMID:16407166 PMID:16598202 PMID:16687628 PMID:16751799 PMID:17015710 PMID:17019405 PMID:17030193 PMID:17084873 PMID:17290005 PMID:19036883 PMID:19048458 PMID:19139408 PMID:19201410 PMID:19403437 PMID:19439812 PMID:20064974 PMID:20307981 PMID:20860658 PMID:21354099 PMID:21557540 PMID:21597168 PMID:21962020 PMID:22070604 PMID:22593575 PMID:22989705 PMID:23150725 PMID:23795773 PMID:23811337 PMID:23843199 PMID:25679220 PMID:26643070 PMID:27350165 PMID:28744220 PMID:29669060 PMID:29734669 PMID:30130594 PMID:30965670 PMID:31016361 PMID:32407875 PMID:32473317 PMID:37044004 More...
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARGC1A
PPARG coactivator 1 alpha
decreases expression multiple interactions
ISO EXP
pioglitazone results in decreased expression of PPARGC1A mRNA Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARGC1A protein]
CTD
PMID:22456468 PMID:27366949
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPBP
pro-platelet basic protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of PPBP mRNA
CTD
PMID:27935865
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
G
PPP1R3A
protein phosphatase 1 regulatory subunit 3A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PPP1R3A mRNA
CTD
PMID:27935865
NCBI chr 7:113,876,777...113,919,009
Ensembl chr 7:113,876,777...114,075,920
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PPP1R3C mRNA
CTD
PMID:27935865
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PPP2CA
protein phosphatase 2 catalytic subunit alpha
increases expression
EXP
Pioglitazone results in increased expression of PPP2CA mRNA
CTD
PMID:32589349
NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
G
PPP2R2B
protein phosphatase 2 regulatory subunit Bbeta
increases expression
EXP
Pioglitazone results in increased expression of PPP2R2B mRNA
CTD
PMID:32589349
NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
multiple interactions
EXP
PRKAA1 protein affects the reaction [pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]]; PRKAA1 protein affects the reaction [pioglitazone results in increased expression of CDKN1B protein]; PRKAA1 protein affects the reaction [pioglitazone results in increased phosphorylation of RPTOR protein]
CTD
PMID:26643070
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
G
PRKCA
protein kinase C alpha
decreases expression multiple interactions
EXP
Pioglitazone results in decreased expression of PRKCA mRNA [Metformin co-treated with Pioglitazone] results in decreased expression of PRKCA mRNA
CTD
PMID:32589349
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCG
protein kinase C gamma
increases expression
EXP
Pioglitazone results in increased expression of PRKCG mRNA
CTD
PMID:32589349
NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
G
PRKCQ
protein kinase C theta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRKCQ mRNA
CTD
PMID:27935865
NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301
G
PRKG1
protein kinase cGMP-dependent 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRKG1 mRNA
CTD
PMID:27935865
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PRNP
prion protein (Kanno blood group)
multiple interactions increases expression
EXP
GW 1929 inhibits the reaction [Pioglitazone results in increased expression of PRNP protein]; luzindole inhibits the reaction [Pioglitazone results in increased expression of PRNP protein]; Melatonin promotes the reaction [Pioglitazone results in increased expression of PRNP protein]; Pioglitazone promotes the reaction [Melatonin results in increased expression of PRNP protein]; PRNP protein promotes the reaction [Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in decreased expression of RGN protein]]]; PRNP protein promotes the reaction [Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in increased expression of CDKN1A protein]]]; PRNP protein promotes the reaction [Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in decreased expression of RGN protein]]]; PRNP protein promotes the reaction [Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in increased expression of CDKN1A protein]]]
CTD
PMID:29734669
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
PROK2
prokineticin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of PROK2 mRNA
CTD
PMID:27935865
NCBI chr 3:71,771,655...71,785,148
Ensembl chr 3:71,771,655...71,785,206
G
PRR32
proline rich 32
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRR32 mRNA
CTD
PMID:27935865
NCBI chr X:126,819,729...126,821,786
Ensembl chr X:126,819,729...126,821,786
G
PRR33
proline rich 33
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRR33 mRNA
CTD
PMID:27935865
NCBI chr11:1,887,987...1,917,708
Ensembl chr11:1,888,078...1,891,895
G
PRSS2
serine protease 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of PRSS2 mRNA
CTD
PMID:27935865
NCBI chr 7:142,770,970...142,774,560
Ensembl chr 7:142,760,398...142,774,564
G
PRXL2B
peroxiredoxin like 2B
decreases expression
EXP
Pioglitazone results in decreased expression of PRXL2B mRNA
CTD
PMID:30031879
NCBI chr 1:2,586,523...2,591,468
Ensembl chr 1:2,586,491...2,591,469
G
PSORS1C2
psoriasis susceptibility 1 candidate 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of PSORS1C2 mRNA
CTD
PMID:27935865
NCBI chr 6:31,137,534...31,139,066
Ensembl chr 6:31,137,534...31,139,066
G
PTEN
phosphatase and tensin homolog
increases expression
EXP
Pioglitazone results in increased expression of PTEN mRNA
CTD
PMID:32589349
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PTGFR
prostaglandin F receptor
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PTGFR mRNA
CTD
PMID:27935865
NCBI chr 1:78,490,974...78,540,701
Ensembl chr 1:78,303,884...78,540,701
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression decreases expression
ISO EXP
[Atorvastatin co-treated with Pioglitazone] results in increased expression of PTGS2 protein Pioglitazone results in increased expression of PTGS2 mRNA pioglitazone results in decreased expression of PTGS2 protein pioglitazone results in decreased expression of PTGS2 mRNA
CTD
PMID:15817521 PMID:16386242 PMID:16908763 PMID:32816093
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PVALB
parvalbumin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PVALB mRNA
CTD
PMID:27935865
NCBI chr22:36,800,703...36,819,499
Ensembl chr22:36,800,684...36,819,479
G
PXMP2
peroxisomal membrane protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PXMP2 mRNA
CTD
PMID:27935865
NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985
G
PYGM
glycogen phosphorylase, muscle associated
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PYGM mRNA
CTD
PMID:27935865
NCBI chr11:64,746,389...64,760,715
Ensembl chr11:64,746,389...64,759,974
G
RALYL
RALY RNA binding protein like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RALYL mRNA
CTD
PMID:27935865
NCBI chr 8:84,182,787...84,921,844
Ensembl chr 8:84,182,787...84,921,844
G
RANBP2
RAN binding protein 2
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr 2:108,719,482...109,842,301
Ensembl chr 2:108,719,482...108,785,810
G
RASD2
RASD family member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RASD2 mRNA
CTD
PMID:27935865
NCBI chr22:35,532,806...35,553,999
Ensembl chr22:35,540,831...35,553,999
G
RASL12
RAS like family 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RASL12 mRNA
CTD
PMID:27935865
NCBI chr15:65,045,580...65,076,667
Ensembl chr15:65,053,337...65,076,690
G
RB1
RB transcriptional corepressor 1
multiple interactions
EXP
pioglitazone results in decreased phosphorylation of and results in decreased expression of RB1 protein
CTD
PMID:15729575
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RCAN2
regulator of calcineurin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RCAN2 mRNA
CTD
PMID:27935865
NCBI chr 6:46,220,736...46,491,970
Ensembl chr 6:46,220,736...46,491,972
G
RDH10
retinol dehydrogenase 10
increases expression
EXP
Pioglitazone results in increased expression of RDH10 mRNA
CTD
PMID:30031879
NCBI chr 8:73,294,602...73,325,281
Ensembl chr 8:73,294,602...73,325,281
G
REEP3
receptor accessory protein 3
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr10:63,521,401...63,625,128
Ensembl chr10:63,521,401...63,625,128
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions affects expression
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased localization of RELA protein] pioglitazone affects the expression of RELA mRNA; pioglitazone affects the expression of RELA protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of RELA mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of RELA protein]; Fenofibrate promotes the reaction [Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of RELA protein]]; Pioglitazone inhibits the reaction [Aldosterone results in increased activity of RELA protein]; Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of RELA protein]; Pioglitazone inhibits the reaction [Streptozocin results in increased expression of RELA mRNA]; Pioglitazone promotes the reaction [Fenofibrate inhibits the reaction [Doxorubicin results in increased expression of RELA protein]]; T 0070907 inhibits the reaction [Pioglitazone affects the expression of RELA mRNA]; T 0070907 inhibits the reaction [Pioglitazone affects the expression of RELA protein]
CTD
PMID:17015710 PMID:18660453 PMID:28744220 PMID:36988379 PMID:37044004
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RETN
resistin
multiple interactions increases secretion increases expression
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of RETN mRNA; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of RETN mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased secretion of RETN protein] Pioglitazone results in increased secretion of RETN protein Pioglitazone results in increased expression of RETN mRNA
CTD
PMID:27918843 PMID:27935865
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
RETSAT
retinol saturase
multiple interactions increases expression
ISO
[pioglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of RETSAT mRNA pioglitazone results in increased expression of RETSAT mRNA; pioglitazone results in increased expression of RETSAT protein
CTD
PMID:19139408
NCBI chr 2:85,341,955...85,354,528
Ensembl chr 2:85,341,955...85,354,531
G
RGCC
regulator of cell cycle
decreases expression
EXP
Pioglitazone results in decreased expression of RGCC mRNA
CTD
PMID:30031879
NCBI chr13:41,457,550...41,470,871
Ensembl chr13:41,457,550...41,470,871
G
RGN
regucalcin
multiple interactions
EXP
Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in decreased expression of RGN protein]]; Pioglitazone inhibits the reaction [Indican results in decreased expression of RGN protein]; Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in decreased expression of RGN protein]]; PRNP protein promotes the reaction [Melatonin promotes the reaction [Pioglitazone inhibits the reaction [Indican results in decreased expression of RGN protein]]]; PRNP protein promotes the reaction [Pioglitazone promotes the reaction [Melatonin inhibits the reaction [Indican results in decreased expression of RGN protein]]]
CTD
PMID:29734669
NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314
G
RGS1
regulator of G protein signaling 1
decreases expression
EXP
Pioglitazone results in decreased expression of RGS1 mRNA
CTD
PMID:30031879
NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024
G
RGS13
regulator of G protein signaling 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RGS13 mRNA
CTD
PMID:27935865
NCBI chr 1:192,636,147...192,660,311
Ensembl chr 1:192,636,138...192,660,311
G
RGS5
regulator of G protein signaling 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RGS5 mRNA
CTD
PMID:27935865
NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
G
RGS7BP
regulator of G protein signaling 7 binding protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RGS7BP mRNA
CTD
PMID:27935865
NCBI chr 5:64,506,015...64,612,319
Ensembl chr 5:64,506,015...64,612,319
G
RHEB
Ras homolog, mTORC1 binding
increases expression
EXP
Pioglitazone results in increased expression of RHEB mRNA
CTD
PMID:32589349
NCBI chr 7:151,466,012...151,519,895
Ensembl chr 7:151,466,012...151,520,120
G
RICTOR
RPTOR independent companion of MTOR complex 2
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of RICTOR mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]
CTD
PMID:20847119 PMID:32589349
NCBI chr 5:38,937,920...39,074,399
Ensembl chr 5:38,937,920...39,074,402
G
RIOX1
ribosomal oxygenase 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA
CTD
PMID:20847119
NCBI chr14:73,490,933...73,493,394
Ensembl chr14:73,490,933...73,493,394
G
RNASE6
ribonuclease A family member k6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RNASE6 mRNA
CTD
PMID:27935865
NCBI chr14:20,781,070...20,782,467
Ensembl chr14:20,781,268...20,782,467
G
RNU1-3
RNA, U1 small nuclear 3
decreases expression
EXP
Pioglitazone results in decreased expression of RNU1-3 mRNA
CTD
PMID:30031879
NCBI chr 1:16,666,785...16,666,948
Ensembl chr 1:16,666,785...16,666,948
G
RNVU1-18
RNA, variant U1 small nuclear 18
decreases expression
EXP
Pioglitazone results in decreased expression of RNVU1-18 mRNA
CTD
PMID:30031879
NCBI chr 1:143,729,407...143,729,570
Ensembl chr 1:143,729,407...143,729,570
G
RNVU1-7
RNA, variant U1 small nuclear 7
decreases expression
EXP
Pioglitazone results in decreased expression of RNVU1-7 mRNA
CTD
PMID:30031879
NCBI chr 1:148,038,753...148,038,916
Ensembl chr 1:148,038,753...148,038,916
G
ROBO3
roundabout guidance receptor 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of ROBO3 mRNA
CTD
PMID:27935865
NCBI chr11:124,865,432...124,881,471
Ensembl chr11:124,865,432...124,881,471
G
RORC
RAR related orphan receptor C
increases expression
ISO
pioglitazone results in increased expression of RORC mRNA
CTD
PMID:9543393
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
RPL3L
ribosomal protein L3 like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RPL3L mRNA
CTD
PMID:27935865
NCBI chr16:1,943,974...1,954,689
Ensembl chr16:1,943,974...1,957,606
G
RPS6
ribosomal protein S6
decreases phosphorylation decreases expression multiple interactions
EXP
pioglitazone results in decreased phosphorylation of RPS6 protein Pioglitazone results in decreased expression of RPS6 mRNA pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]; PRKAA1 protein affects the reaction [pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]]
CTD
PMID:26643070 PMID:32589349
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
G
RPS6KA1
ribosomal protein S6 kinase A1
increases expression
EXP
Pioglitazone results in increased expression of RPS6KA1 mRNA
CTD
PMID:32589349
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
RPS6KA2
ribosomal protein S6 kinase A2
multiple interactions increases expression
EXP
[Metformin co-treated with Pioglitazone] results in increased expression of RPS6KA2 mRNA Pioglitazone results in increased expression of RPS6KA2 mRNA
CTD
PMID:32589349
NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451
G
RPS6KA5
ribosomal protein S6 kinase A5
multiple interactions
EXP
[Metformin co-treated with Pioglitazone] results in decreased expression of RPS6KA5 mRNA
CTD
PMID:32589349
NCBI chr14:90,847,861...91,060,641
Ensembl chr14:90,847,861...91,060,641
G
RPS6KB1
ribosomal protein S6 kinase B1
multiple interactions decreases phosphorylation
EXP
pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6KB1 protein] pioglitazone results in decreased phosphorylation of RPS6KB1 protein
CTD
PMID:26643070
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
RPTOR
regulatory associated protein of MTOR complex 1
increases phosphorylation multiple interactions
EXP
pioglitazone results in increased phosphorylation of RPTOR protein PRKAA1 protein affects the reaction [pioglitazone results in increased phosphorylation of RPTOR protein]
CTD
PMID:26643070
NCBI chr17:80,544,838...80,966,368
Ensembl chr17:80,544,819...80,966,371
G
RPUSD2
RNA pseudouridine synthase domain containing 2
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA
CTD
PMID:20847119
NCBI chr15:40,569,299...40,574,949
Ensembl chr15:40,569,299...40,574,949
G
RSPO1
R-spondin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RSPO1 mRNA
CTD
PMID:27935865
NCBI chr 1:37,611,350...37,634,892
Ensembl chr 1:37,611,350...37,634,892
G
RTL3
retrotransposon Gag like 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RTL3 mRNA
CTD
PMID:27935865
NCBI chr X:78,656,068...78,659,328
Ensembl chr X:78,656,068...78,659,328
G
RTN2
reticulon 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RTN2 mRNA
CTD
PMID:27935865
NCBI chr19:45,485,294...45,497,047
Ensembl chr19:45,485,294...45,497,055
G
RUNX1T1
RUNX1 partner transcriptional co-repressor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:27935865
NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,972...92,103,385
G
RXRA
retinoid X receptor alpha
multiple interactions
EXP
pioglitazone results in increased activity of [PPARA protein binds to RXRA protein]; pioglitazone results in increased activity of [PPARD protein binds to RXRA protein]; pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein]
CTD
PMID:11779144
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
RYR1
ryanodine receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RYR1 mRNA
CTD
PMID:27935865
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
G
S100A8
S100 calcium binding protein A8
multiple interactions decreases expression increases expression
ISO EXP
[pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of S100A8 mRNA Pioglitazone results in decreased expression of S100A8 mRNA pioglitazone results in increased expression of S100A8 mRNA
CTD
PMID:28138970 PMID:28263783 PMID:30031879
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
multiple interactions increases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of S100A9 mRNA; [pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of S100A9 mRNA pioglitazone results in increased expression of S100A9 mRNA
CTD
PMID:27935865 PMID:28138970 PMID:28263783
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
SAA3P
serum amyloid A3, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SAA3 mRNA
CTD
PMID:27935865
NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132 Ensembl chr11:18,112,472...18,116,132
G
SBK2
SH3 domain binding kinase family member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SBK2 mRNA
CTD
PMID:27935865
NCBI chr19:55,528,611...55,537,133
Ensembl chr19:55,528,611...55,537,133
G
SBK3
SH3 domain binding kinase family member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SBK3 mRNA
CTD
PMID:27935865
NCBI chr19:55,540,656...55,545,543
Ensembl chr19:55,540,656...55,545,543
G
SBSPON
somatomedin B and thrombospondin type 1 domain containing
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SBSPON mRNA
CTD
PMID:27935865
NCBI chr 8:73,064,543...73,093,172
Ensembl chr 8:73,064,543...73,124,088
G
SCARB1
scavenger receptor class B member 1
decreases expression
ISO
pioglitazone results in decreased expression of SCARB1 mRNA
CTD
PMID:20503262
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SCD
stearoyl-CoA desaturase
multiple interactions
EXP
Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]
CTD
PMID:32613381
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SCGB3A2
secretoglobin family 3A member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCGB3A2 mRNA
CTD
PMID:27935865
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
G
SCN2A
sodium voltage-gated channel alpha subunit 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCN2A mRNA
CTD
PMID:27935865
NCBI chr 2:165,239,414...165,392,304
Ensembl chr 2:165,194,993...165,392,310
G
SCN4A
sodium voltage-gated channel alpha subunit 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCN4A mRNA
CTD
PMID:27935865
NCBI chr17:63,938,554...63,972,918
Ensembl chr17:63,938,554...63,972,918
G
SCN4B
sodium voltage-gated channel beta subunit 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCN4B mRNA
CTD
PMID:27935865
NCBI chr11:118,133,377...118,152,823
Ensembl chr11:118,133,377...118,152,888
G
SCN7A
sodium voltage-gated channel alpha subunit 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCN7A mRNA
CTD
PMID:27935865
NCBI chr 2:166,403,573...166,494,249
Ensembl chr 2:166,403,573...166,611,482
G
SCNN1G
sodium channel epithelial 1 subunit gamma
multiple interactions increases expression
ISO
pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron] pioglitazone results in increased expression of SCNN1G mRNA
CTD
PMID:16007095
NCBI chr16:23,182,745...23,216,883
Ensembl chr16:23,182,745...23,216,883
G
SCUBE1
signal peptide, CUB domain and EGF like domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCUBE1 mRNA
CTD
PMID:27935865
NCBI chr22:43,197,280...43,343,372
Ensembl chr22:43,197,280...43,343,372
G
SEC31B
SEC31 homolog B, COPII coat complex component
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SEC31B mRNA
CTD
PMID:27935865
NCBI chr10:100,486,647...100,519,861
Ensembl chr10:100,486,646...100,519,864
G
SELE
selectin E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SELE mRNA
CTD
PMID:27935865
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
SELP
selectin P
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SELP mRNA
CTD
PMID:27935865
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINE1
serpin family E member 1
multiple interactions increases expression
ISO EXP
pioglitazone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of SERPINE1 mRNA] pioglitazone results in increased expression of SERPINE1 mRNA
CTD
PMID:16598202 PMID:21757225
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFRP2
secreted frizzled related protein 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SFRP2 mRNA
CTD
PMID:27935865
NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083
G
SFRP4
secreted frizzled related protein 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SFRP4 mRNA
CTD
PMID:27935865
NCBI chr 7:37,905,932...37,916,817
Ensembl chr 7:37,905,932...38,025,695
G
SFTPA1
surfactant protein A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SFTPA1 mRNA
CTD
PMID:27935865
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
G
SGCA
sarcoglycan alpha
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SGCA mRNA
CTD
PMID:27935865
NCBI chr17:50,166,005...50,175,928
Ensembl chr17:50,164,214...50,175,928
G
SGCE
sarcoglycan epsilon
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SGCE mRNA
CTD
PMID:27935865
NCBI chr 7:94,584,980...94,656,133
Ensembl chr 7:94,524,204...94,656,572
G
SGCG
sarcoglycan gamma
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SGCG mRNA
CTD
PMID:27935865
NCBI chr13:23,160,508...23,325,162
Ensembl chr13:23,180,979...23,325,162
G
SGK1
serum/glucocorticoid regulated kinase 1
decreases expression
EXP
Pioglitazone results in decreased expression of SGK1 mRNA
CTD
PMID:32589349
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
G
SH2D5
SH2 domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SH2D5 mRNA
CTD
PMID:27935865
NCBI chr 1:20,719,731...20,732,703
Ensembl chr 1:20,719,731...20,732,837
G
SH2D7
SH2 domain containing 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SH2D7 mRNA
CTD
PMID:27935865
NCBI chr15:78,090,122...78,104,362
Ensembl chr15:78,077,808...78,104,370
G
SHE
Src homology 2 domain containing E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SHE mRNA
CTD
PMID:27935865
NCBI chr 1:154,469,637...154,502,412
Ensembl chr 1:154,469,772...154,502,412
G
SLC17A8
solute carrier family 17 member 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC17A8 mRNA
CTD
PMID:27935865
NCBI chr12:100,357,074...100,422,055
Ensembl chr12:100,357,074...100,422,055
G
SLC22A2
solute carrier family 22 member 2
multiple interactions
EXP
pioglitazone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC25A24
solute carrier family 25 member 24
decreases expression
EXP
Pioglitazone results in decreased expression of SLC25A24 mRNA
CTD
PMID:30031879
NCBI chr 1:108,134,043...108,200,343
Ensembl chr 1:108,134,043...108,200,849
G
SLC25A34
solute carrier family 25 member 34
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC25A34 mRNA
CTD
PMID:27935865
NCBI chr 1:15,736,258...15,741,392
Ensembl chr 1:15,736,258...15,741,392
G
SLC25A53
solute carrier family 25 member 53
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC25A53 mRNA
CTD
PMID:27935865
NCBI chr X:104,099,214...104,157,009
Ensembl chr X:104,099,214...104,157,009
G
SLC26A7
solute carrier family 26 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC26A7 mRNA
CTD
PMID:27935865
NCBI chr 8:91,209,496...91,398,155
Ensembl chr 8:91,209,494...91,398,155
G
SLC27A1
solute carrier family 27 member 1
increases expression
ISO
pioglitazone results in increased expression of SLC27A1 mRNA
CTD
PMID:20723549
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
G
SLC2A14
solute carrier family 2 member 14
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A14 mRNA
CTD
PMID:20847119
NCBI chr12:7,812,514...7,891,196
Ensembl chr12:7,812,512...7,891,148
G
SLC2A3
solute carrier family 2 member 3
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA
CTD
PMID:20847119
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC2A4
solute carrier family 2 member 4
multiple interactions
ISO
pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A4 mRNA]
CTD
PMID:27350165
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC2A5
solute carrier family 2 member 5
multiple interactions decreases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC2A5 mRNA Pioglitazone results in decreased expression of SLC2A5 mRNA
CTD
PMID:27935865 PMID:30031879
NCBI chr 1:9,035,106...9,094,195
Ensembl chr 1:9,035,106...9,088,478
G
SLC2A6
solute carrier family 2 member 6
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SLC2A6 mRNA
CTD
PMID:27935865
NCBI chr 9:133,471,094...133,479,099
Ensembl chr 9:133,471,094...133,479,127
G
SLC38A5
solute carrier family 38 member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC38A5 mRNA
CTD
PMID:27935865
NCBI chr X:48,458,544...48,470,260
Ensembl chr X:48,458,537...48,470,260
G
SLC4A5
solute carrier family 4 member 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC4A5 mRNA
CTD
PMID:27935865
NCBI chr 2:74,216,242...74,343,416
Ensembl chr 2:74,216,242...74,343,416
G
SLC5A7
solute carrier family 5 member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC5A7 mRNA
CTD
PMID:27935865
NCBI chr 2:107,986,524...108,013,994
Ensembl chr 2:107,986,523...108,013,994
G
SLC6A12
solute carrier family 6 member 12
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SLC6A12 mRNA
CTD
PMID:27935865
NCBI chr12:183,848...214,157
Ensembl chr12:190,077...214,570
G
SLC6A15
solute carrier family 6 member 15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC6A15 mRNA
CTD
PMID:27935865
NCBI chr12:84,859,491...84,912,799
Ensembl chr12:84,859,491...84,913,629
G
SLC6A17
solute carrier family 6 member 17
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC6A17 mRNA
CTD
PMID:27935865
NCBI chr 1:110,150,494...110,202,202
Ensembl chr 1:110,150,494...110,202,202
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
Pioglitazone results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLCO1B1
solute carrier organic anion transporter family member 1B1
multiple interactions
EXP
Pioglitazone inhibits the reaction [SLCO1B1 protein results in increased uptake of Atorvastatin]
CTD
PMID:23121773
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
G
SLCO1B3
solute carrier organic anion transporter family member 1B3
multiple interactions
EXP
pioglitazone affects the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]
CTD
PMID:23121773
NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
G
SLCO2B1
solute carrier organic anion transporter family member 2B1
multiple interactions
EXP
pioglitazone affects the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein]
CTD
PMID:23121773
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
G
SLCO4C1
solute carrier organic anion transporter family member 4C1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLCO4C1 mRNA
CTD
PMID:27935865
NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284
G
SLCO5A1
solute carrier organic anion transporter family member 5A1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLCO5A1 mRNA
CTD
PMID:27935865
NCBI chr 8:69,667,046...69,834,978
Ensembl chr 8:69,667,046...69,834,978
G
SLIT1
slit guidance ligand 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SLIT1 mRNA
CTD
PMID:27935865
NCBI chr10:96,998,038...97,185,959
Ensembl chr10:96,998,038...97,185,959
G
SLN
sarcolipin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLN mRNA
CTD
PMID:27935865
NCBI chr11:107,707,378...107,712,056
Ensembl chr11:107,707,378...107,719,693
G
SLTM
SAFB like transcription modulator
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr15:58,879,050...58,933,679
Ensembl chr15:58,879,050...58,933,679
G
SMAD9
SMAD family member 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SMAD9 mRNA
CTD
PMID:27935865
NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,887
G
SMIM10L2A
small integral membrane protein 10 like 2A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of SMIM10L2A mRNA
CTD
PMID:27935865
NCBI chr X:135,421,944...135,428,075
Ensembl chr X:135,421,944...135,428,075
G
SMOC1
SPARC related modular calcium binding 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SMOC1 mRNA
CTD
PMID:27935865
NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366
G
SMPX
small muscle protein X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SMPX mRNA
CTD
PMID:27935865
NCBI chr X:21,705,978...21,758,116
Ensembl chr X:21,705,978...21,758,116
G
SMTNL1
smoothelin like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SMTNL1 mRNA
CTD
PMID:27935865
NCBI chr11:57,537,595...57,550,272
Ensembl chr11:57,537,595...57,550,272
G
SNCAIP
synuclein alpha interacting protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SNCAIP mRNA
CTD
PMID:27935865
NCBI chr 5:122,311,353...122,464,219
Ensembl chr 5:122,311,354...122,464,219
G
SOD1
superoxide dismutase 1
increases expression multiple interactions
EXP ISO
pioglitazone results in increased expression of SOD1 mRNA; pioglitazone results in increased expression of SOD1 protein pioglitazone inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SOD1 mRNA]
CTD
PMID:11172467 PMID:18513333
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
affects activity
ISO
pioglitazone affects the activity of SOD2 protein
CTD
PMID:21962020
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SORCS1
sortilin related VPS10 domain containing receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SORCS1 mRNA
CTD
PMID:27935865
NCBI chr10:106,573,663...107,181,138
Ensembl chr10:106,573,663...107,164,706
G
SOWAHC
sosondowah ankyrin repeat domain family member C
increases expression
EXP
Pioglitazone results in increased expression of SOWAHC mRNA
CTD
PMID:30031879
NCBI chr 2:109,614,364...109,618,990
Ensembl chr 2:109,614,364...109,618,990
G
SOX10
SRY-box transcription factor 10
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SOX10 mRNA
CTD
PMID:27935865
NCBI chr22:37,972,312...37,984,555
Ensembl chr22:37,970,686...37,987,422
G
SOX8
SRY-box transcription factor 8
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SOX8 mRNA
CTD
PMID:27935865
NCBI chr16:981,770...986,979
Ensembl chr16:981,444...986,979
G
SP7
Sp7 transcription factor
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA]
CTD
PMID:32473317
NCBI chr12:53,326,575...53,344,793
Ensembl chr12:53,326,575...53,345,315
G
SPARCL1
SPARC like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SPARCL1 mRNA
CTD
PMID:27935865
NCBI chr 4:87,473,335...87,529,376
Ensembl chr 4:87,473,335...87,531,061
G
SPEG
striated muscle enriched protein kinase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SPEG mRNA
CTD
PMID:27935865
NCBI chr 2:219,434,843...219,493,629
Ensembl chr 2:219,434,843...219,493,629
G
SPINK9
serine peptidase inhibitor Kazal type 9
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPINK12 mRNA
CTD
PMID:27935865
NCBI chr 5:148,321,305...148,339,852
Ensembl chr 5:148,321,203...148,339,852
G
SPMIP11
sperm microtubule inner protein 11
increases expression
ISO
Pioglitazone results in increased expression of NPHS1 mRNA; Pioglitazone results in increased expression of NPHS1 protein
CTD
PMID:16687628
NCBI chr12:48,727,435...48,771,459
Ensembl chr12:48,727,435...48,765,790
G
SPOCD1
SPOC domain containing 1
increases expression
EXP
Pioglitazone results in increased expression of SPOCD1 mRNA
CTD
PMID:30031879
NCBI chr 1:31,790,422...31,816,022
Ensembl chr 1:31,790,422...31,816,022
G
SPON1
spondin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SPON1 mRNA
CTD
PMID:27935865
NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133
G
SPP1
secreted phosphoprotein 1
multiple interactions
ISO
pioglitazone inhibits the reaction [Streptozocin results in increased expression of SPP1 mRNA]; pioglitazone inhibits the reaction [Streptozocin results in increased expression of SPP1 protein]
CTD
PMID:16979161
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRR1B
small proline rich protein 1B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPRR1B mRNA
CTD
PMID:27935865
NCBI chr 1:153,031,203...153,032,900
Ensembl chr 1:153,031,203...153,032,900
G
SPRR2A
small proline rich protein 2A
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of SPRR2H mRNA
CTD
PMID:27935865
NCBI chr 1:153,056,120...153,057,512
Ensembl chr 1:153,056,120...153,057,512
G
SPRR2B
small proline rich protein 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPRR2B mRNA
CTD
PMID:27935865
NCBI chr 1:153,070,226...153,087,799
Ensembl chr 1:153,070,226...153,071,611
G
SPRR2D
small proline rich protein 2D
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPRR2D mRNA
CTD
PMID:27935865
NCBI chr 1:153,039,732...153,041,120
Ensembl chr 1:153,039,732...153,041,931
G
SPRR2E
small proline rich protein 2E
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPRR2E mRNA
CTD
PMID:27935865
NCBI chr 1:153,093,135...153,094,526
Ensembl chr 1:153,093,135...153,106,184
G
SPRR2F
small proline rich protein 2F
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SPRR2F mRNA
CTD
PMID:27935865
NCBI chr 1:153,112,121...153,119,468
Ensembl chr 1:153,112,121...153,113,516
G
SPRR2G
small proline rich protein 2G
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of SPRR2G mRNA
CTD
PMID:27935865
NCBI chr 1:153,149,582...153,203,278
Ensembl chr 1:153,149,582...153,150,890
G
SRL
sarcalumenin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SRL mRNA
CTD
PMID:27935865
NCBI chr16:4,189,374...4,242,080
Ensembl chr16:4,189,374...4,242,080
G
SRPX
sushi repeat containing protein X-linked
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SRPX mRNA
CTD
PMID:27935865
NCBI chr X:38,149,339...38,220,871
Ensembl chr X:38,149,336...38,220,924
G
ST3GAL1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 8:133,454,848...133,571,887
Ensembl chr 8:133,454,848...133,571,926
G
STAC3
SH3 and cysteine rich domain 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of STAC3 mRNA
CTD
PMID:27935865
NCBI chr12:57,243,458...57,251,187
Ensembl chr12:57,243,453...57,251,188
G
STK11
serine/threonine kinase 11
increases expression
EXP
Pioglitazone results in increased expression of STK11 mRNA
CTD
PMID:32589349
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
G
STX1B
syntaxin 1B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of STX1B mRNA
CTD
PMID:27935865
NCBI chr16:30,989,256...31,010,638
Ensembl chr16:30,989,256...31,010,638
G
STYXL2
serine/threonine/tyrosine interacting like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of STYXL2 mRNA
CTD
PMID:27935865
NCBI chr 1:167,094,075...167,129,165
Ensembl chr 1:167,094,075...167,129,165
G
SULT1C2
sulfotransferase family 1C member 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SULT1C2 mRNA
CTD
PMID:27935865
NCBI chr 2:108,288,895...108,309,915
Ensembl chr 2:108,288,639...108,309,915
G
SULT1C3
sulfotransferase family 1C member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SULT1C1 mRNA
CTD
PMID:27935865
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
SUSD5
sushi domain containing 5
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SUSD5 mRNA
CTD
PMID:27935865
NCBI chr 3:33,150,043...33,218,810
Ensembl chr 3:33,150,043...33,218,810
G
SVEP1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SVEP1 mRNA
CTD
PMID:27935865
NCBI chr 9:110,365,248...110,579,741
Ensembl chr 9:110,365,248...110,579,880
G
SVOPL
SVOP like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SVOPL mRNA
CTD
PMID:27935865
NCBI chr 7:138,594,285...138,701,362
Ensembl chr 7:138,594,285...138,701,362
G
SYN1
synapsin I
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of SYN1 mRNA
CTD
PMID:27935865
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
G
SYN2
synapsin II
multiple interactions
ISO
Pioglitazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYN2 protein]
CTD
PMID:32735850
NCBI chr 3:12,004,388...12,192,032
Ensembl chr 3:12,004,388...12,192,032
G
SYNPO2
synaptopodin 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SYNPO2 mRNA
CTD
PMID:27935865
NCBI chr 4:118,850,681...119,061,247
Ensembl chr 4:118,850,688...119,061,247
G
SYPL2
synaptophysin like 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SYPL2 mRNA
CTD
PMID:27935865
NCBI chr 1:109,466,546...109,482,134
Ensembl chr 1:109,466,546...109,482,134
G
TAGLN
transgelin
multiple interactions decreases expression
ISO EXP
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TAGLN mRNA Pioglitazone results in decreased expression of TAGLN mRNA
CTD
PMID:27935865 PMID:30031879
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TARM1
T cell-interacting, activating receptor on myeloid cells 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TARM1 mRNA
CTD
PMID:27935865
NCBI chr19:54,069,895...54,081,365
Ensembl chr19:54,069,895...54,081,365
G
TAS2R4
taste 2 receptor member 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TAS2R108 mRNA
CTD
PMID:27935865
NCBI chr 7:141,776,674...141,781,691
Ensembl chr 7:141,776,674...141,781,691
G
TBX15
T-box transcription factor 15
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TBX15 mRNA
CTD
PMID:27935865
NCBI chr 1:118,883,047...118,989,510
Ensembl chr 1:118,883,046...118,989,556
G
TBX4
T-box transcription factor 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TBX4 mRNA
CTD
PMID:27935865
NCBI chr17:61,452,422...61,485,110
Ensembl chr17:61,452,404...61,485,110
G
TCAP
titin-cap
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TCAP mRNA
CTD
PMID:27935865
NCBI chr17:39,665,349...39,666,554
Ensembl chr17:39,665,349...39,666,554
G
TCEAL7
transcription elongation factor A like 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TCEAL7 mRNA
CTD
PMID:27935865
NCBI chr X:103,330,239...103,332,326
Ensembl chr X:103,330,229...103,332,326
G
TDH
L-threonine dehydrogenase (pseudogene)
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TDH mRNA
CTD
PMID:27935865
NCBI chr 8:11,339,637...11,368,452
Ensembl chr 8:11,339,637...11,368,452 Ensembl chr 8:11,339,637...11,368,452
G
TDO2
tryptophan 2,3-dioxygenase
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TDO2 mRNA
CTD
PMID:27935865
NCBI chr 4:155,903,696...155,920,406
Ensembl chr 4:155,854,738...155,920,406
G
TELO2
telomere maintenance 2
increases expression multiple interactions
EXP
Pioglitazone results in increased expression of TELO2 mRNA [Metformin co-treated with Pioglitazone] results in increased expression of TELO2 mRNA
CTD
PMID:32589349
NCBI chr16:1,493,360...1,510,454
Ensembl chr16:1,493,344...1,510,457
G
TET1
tet methylcytosine dioxygenase 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TET1 mRNA
CTD
PMID:27935865
NCBI chr10:68,560,337...68,694,487
Ensembl chr10:68,560,337...68,694,487
G
TFAM
transcription factor A, mitochondrial
decreases expression
EXP
pioglitazone results in decreased expression of TFAM mRNA
CTD
PMID:20860658
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
G
TFF2
trefoil factor 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TFF2 mRNA
CTD
PMID:27935865
NCBI chr21:42,346,357...42,350,994
Ensembl chr21:42,346,357...42,350,997
G
TG
thyroglobulin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TG mRNA
CTD
PMID:27935865
NCBI chr 8:132,866,958...133,134,899
Ensembl chr 8:132,866,958...133,134,903
G
TGFB1
transforming growth factor beta 1
multiple interactions decreases expression
ISO EXP
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of TGFB1 protein] Pioglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] pioglitazone affects the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; pioglitazone inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; pioglitazone inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA] pioglitazone results in decreased expression of TGFB1 mRNA
CTD
PMID:12055599 PMID:16484506 PMID:16611854 PMID:17015710 PMID:32613381
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGM7
transglutaminase 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TGM7 mRNA
CTD
PMID:27935865
NCBI chr15:43,276,271...43,302,255
Ensembl chr15:43,276,271...43,302,255
G
THBS1
thrombospondin 1
multiple interactions
ISO
pioglitazone inhibits the reaction [Streptozocin results in increased expression of THBS1 mRNA]; pioglitazone inhibits the reaction [Streptozocin results in increased expression of THBS1 protein]
CTD
PMID:17063547
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
THRSP
thyroid hormone responsive
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of THRSP mRNA
CTD
PMID:27935865
NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351
G
TIMP1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
pioglitazone affects the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]
CTD
PMID:16484506
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TLE6
TLE family member 6, subcortical maternal complex member
increases expression
EXP
Pioglitazone results in increased expression of TLE6 mRNA
CTD
PMID:30031879
NCBI chr19:2,977,401...2,995,179
Ensembl chr19:2,977,538...2,995,179
G
TM4SF19
transmembrane 4 L six family member 19
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TM4SF19 mRNA
CTD
PMID:27935865
NCBI chr 3:196,323,547...196,338,388
Ensembl chr 3:196,319,342...196,338,503
G
TMEM132C
transmembrane protein 132C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TMEM132C mRNA
CTD
PMID:27935865
NCBI chr12:128,267,170...128,707,911
Ensembl chr12:128,267,170...128,707,911
G
TMEM177
transmembrane protein 177
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA
CTD
PMID:20847119
NCBI chr 2:119,679,201...119,723,618
Ensembl chr 2:119,679,167...119,686,507
G
TMEM182
transmembrane protein 182
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TMEM182 mRNA
CTD
PMID:27935865
NCBI chr 2:102,736,935...102,843,838
Ensembl chr 2:102,736,905...103,019,900
G
TMEM200B
transmembrane protein 200B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TMEM200B mRNA
CTD
PMID:27935865
NCBI chr 1:29,119,429...29,123,903
Ensembl chr 1:29,119,429...29,123,903
G
TMEM213
transmembrane protein 213
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TMEM213 mRNA
CTD
PMID:27935865
NCBI chr 7:138,797,994...138,806,759
Ensembl chr 7:138,797,952...138,838,101
G
TMEM252
transmembrane protein 252
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TMEM252 mRNA
CTD
PMID:27935865
NCBI chr 9:68,536,580...68,540,883
Ensembl chr 9:68,536,580...68,540,883
G
TMEM91
transmembrane protein 91
increases expression
EXP
Pioglitazone results in increased expression of TMEM91 mRNA
CTD
PMID:30031879
NCBI chr19:41,363,947...41,384,083
Ensembl chr19:41,350,911...41,384,083
G
TMOD1
tropomodulin 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TMOD1 mRNA
CTD
PMID:27935865
NCBI chr 9:97,501,180...97,601,743
Ensembl chr 9:97,501,180...97,601,743
G
TMOD4
tropomodulin 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TMOD4 mRNA
CTD
PMID:27935865
NCBI chr 1:151,169,987...151,175,981
Ensembl chr 1:151,169,986...151,176,284
G
TNF
tumor necrosis factor
multiple interactions decreases expression affects expression
EXP ISO
Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of SCD mRNA]; Pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein]; Pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CXCL5 protein]; Pioglitazone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIB protein] Pioglitazone results in decreased expression of TNF mRNA pioglitazone affects the expression of TNF protein [Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of TNF mRNA; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA] 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF protein]]; [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; Fenofibrate promotes the reaction [Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of TNF protein]]; Pioglitazone inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of TNF protein]; Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of TNF mRNA]; Pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of TNF protein]; Pioglitazone inhibits the reaction [Cisplatin results in increased expression of TNF mRNA]; Pioglitazone inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; Pioglitazone inhibits the reaction [Fructose results in increased secretion of TNF protein]; Pioglitazone inhibits the reaction [propionic acid results in increased expression of TNF protein]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF mRNA]; Pioglitazone inhibits the reaction [Quinolinic Acid results in increased expression of TNF protein]; Pioglitazone inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Pioglitazone promotes the reaction [Fenofibrate inhibits the reaction [Doxorubicin results in increased expression of TNF protein]]
CTD
PMID:14586007 PMID:15318101 PMID:17055343 PMID:20450929 PMID:22989705 PMID:25679220 PMID:27918843 PMID:28263783 PMID:28744220 PMID:29233026 PMID:30130594 PMID:30343038 PMID:31348919 PMID:32613381 PMID:36988379 PMID:37044004 More...
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP6
TNF alpha induced protein 6
increases expression
EXP
Pioglitazone results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TNFRSF11B
TNF receptor superfamily member 11b
multiple interactions
EXP
Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased secretion of TNFRSF11B protein]
CTD
PMID:31016361
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF1B
TNF receptor superfamily member 1B
increases secretion
ISO
Pioglitazone results in increased secretion of TNFRSF1B protein
CTD
PMID:27918843
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TNNC2
troponin C2, fast skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TNNC2 mRNA
CTD
PMID:27935865
NCBI chr20:45,823,214...45,833,306
Ensembl chr20:45,823,214...45,833,745
G
TNNI2
troponin I2, fast skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TNNI2 mRNA
CTD
PMID:27935865
NCBI chr11:1,838,981...1,841,678
Ensembl chr11:1,838,981...1,841,680
G
TNNT1
troponin T1, slow skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TNNT1 mRNA
CTD
PMID:27935865
NCBI chr19:55,132,698...55,149,206
Ensembl chr19:55,132,698...55,149,206
G
TNNT3
troponin T3, fast skeletal type
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TNNT3 mRNA
CTD
PMID:27935865
NCBI chr11:1,919,552...1,938,702
Ensembl chr11:1,919,703...1,938,706
G
TPI1
triosephosphate isomerase 1
decreases expression
ISO
pioglitazone results in decreased expression of TPI1 mRNA
CTD
PMID:20723549
NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948
G
TRARG1
trafficking regulator of GLUT4 (SLC2A4) 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of TRARG1 mRNA
CTD
PMID:27935865
NCBI chr17:1,279,662...1,300,978
Ensembl chr17:1,279,662...1,300,978
G
TRDN
triadin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TRDN mRNA
CTD
PMID:27935865
NCBI chr 6:123,216,339...123,636,950
Ensembl chr 6:123,216,339...123,637,189
G
TREML1
triggering receptor expressed on myeloid cells like 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TREML1 mRNA
CTD
PMID:27935865
NCBI chr 6:41,149,260...41,155,403
Ensembl chr 6:41,149,337...41,154,347
G
TRIB3
tribbles pseudokinase 3
decreases expression multiple interactions
EXP
Pioglitazone results in decreased expression of TRIB3 mRNA Pioglitazone inhibits the reaction [Arsenic Trioxide results in increased expression of TRIB3 mRNA]
CTD
PMID:32929351
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIL
TLR4 interactor with leucine rich repeats
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TRIL mRNA
CTD
PMID:27935865
NCBI chr 7:28,953,358...28,958,330
Ensembl chr 7:28,953,358...28,958,330
G
TRIM54
tripartite motif containing 54
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TRIM54 mRNA
CTD
PMID:27935865
NCBI chr 2:27,282,429...27,307,435
Ensembl chr 2:27,282,429...27,307,439
G
TRPC3
transient receptor potential cation channel subfamily C member 3
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TRPC3 mRNA
CTD
PMID:27935865
NCBI chr 4:121,874,481...121,952,060
Ensembl chr 4:121,874,481...121,952,060
G
TTC41P
tetratricopeptide repeat domain 41, pseudogene
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TTC41 mRNA
CTD
PMID:27935865
NCBI chr12:103,843,749...103,930,211
Ensembl chr12:103,843,756...103,915,867
G
TTN
titin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TTN mRNA
CTD
PMID:27935865
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TUBB3
tubulin beta 3 class III
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of TUBB3 mRNA
CTD
PMID:27935865
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
G
TXLNB
taxilin beta
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TXLNB mRNA
CTD
PMID:27935865
NCBI chr 6:139,159,162...139,323,950
Ensembl chr 6:139,240,061...139,291,998
G
UBE2U
ubiquitin conjugating enzyme E2 U
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of UBE2U mRNA
CTD
PMID:27935865
NCBI chr 1:64,203,623...64,267,368
Ensembl chr 1:64,203,623...64,267,368
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
increases expression
EXP
Pioglitazone results in increased expression of UGT1A1 mRNA
CTD
PMID:31233785
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
ULK1
unc-51 like autophagy activating kinase 1
multiple interactions increases expression
EXP
[Metformin co-treated with Pioglitazone] results in increased expression of ULK1 mRNA Pioglitazone results in increased expression of ULK1 mRNA
CTD
PMID:32589349
NCBI chr12:131,894,622...131,923,150
Ensembl chr12:131,894,622...131,923,150
G
ULK2
unc-51 like autophagy activating kinase 2
increases expression
EXP
Pioglitazone results in increased expression of ULK2 mRNA
CTD
PMID:32589349
NCBI chr17:19,770,830...19,867,936
Ensembl chr17:19,770,829...19,867,936
G
UMPS
uridine monophosphate synthetase
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA
CTD
PMID:20847119
NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273
G
UNC45B
unc-45 myosin chaperone B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of UNC45B mRNA
CTD
PMID:27935865
NCBI chr17:35,147,817...35,189,345
Ensembl chr17:35,147,817...35,189,345
G
USP13
ubiquitin specific peptidase 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of USP13 mRNA
CTD
PMID:27935865
NCBI chr 3:179,653,040...179,789,401
Ensembl chr 3:179,653,032...179,804,366
G
VASN
vasorin
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr16:4,371,848...4,383,538
Ensembl chr16:4,371,848...4,383,538
G
VAT1L
vesicle amine transport 1 like
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of VAT1L mRNA
CTD
PMID:27935865
NCBI chr16:77,788,564...77,980,107
Ensembl chr16:77,788,564...77,980,107
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
ISO
pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of VCAM1 protein] Pioglitazone inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of VCAM1 protein]; Pioglitazone inhibits the reaction [Streptozocin results in increased expression of VCAM1 mRNA]
CTD
PMID:16979161 PMID:17015710 PMID:30343038
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VEGFA
vascular endothelial growth factor A
multiple interactions increases expression decreases expression
EXP ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA] Pioglitazone results in increased expression of VEGFA mRNA pioglitazone inhibits the reaction [Dietary Fats results in increased expression of VEGFA mRNA] pioglitazone results in decreased expression of VEGFA protein
CTD
PMID:20847119 PMID:22456468 PMID:26281317 PMID:32589349
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFB
vascular endothelial growth factor B
increases expression
EXP
Pioglitazone results in increased expression of VEGFB mRNA
CTD
PMID:32589349
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VLDLR
very low density lipoprotein receptor
increases expression
ISO EXP
pioglitazone results in increased expression of VLDLR mRNA Pioglitazone results in increased expression of VLDLR mRNA
CTD
PMID:19706614 PMID:30031879
NCBI chr 9:2,621,787...2,660,056
Ensembl chr 9:2,621,182...2,660,056
G
VTN
vitronectin
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of VTN mRNA
CTD
PMID:27935865
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
VWA2
von Willebrand factor A domain containing 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of VWA2 mRNA
CTD
PMID:27935865
NCBI chr10:114,239,254...114,294,500
Ensembl chr10:114,239,254...114,294,489
G
WFDC13
WAP four-disulfide core domain 13
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of WFDC13 mRNA
CTD
PMID:27935865
NCBI chr20:45,702,038...45,708,817
Ensembl chr20:45,702,038...45,708,817
G
WNT2B
Wnt family member 2B
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of WNT2B mRNA
CTD
PMID:27935865
NCBI chr 1:112,466,541...112,530,165
Ensembl chr 1:112,466,541...112,530,165
G
WSCD2
WSC domain containing 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of WSCD2 mRNA
CTD
PMID:27935865
NCBI chr12:108,129,288...108,250,537
Ensembl chr12:108,129,288...108,250,537
G
XCR1
X-C motif chemokine receptor 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XCR1 mRNA
CTD
PMID:27935865
NCBI chr 3:46,017,007...46,085,844
Ensembl chr 3:46,016,990...46,085,825
G
XIRP1
xin actin binding repeat containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP1 mRNA
CTD
PMID:27935865
NCBI chr 3:39,183,215...39,192,595
Ensembl chr 3:39,183,210...39,192,596
G
XIRP2
xin actin binding repeat containing 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP2 mRNA
CTD
PMID:27935865
NCBI chr 2:166,888,480...167,259,753
Ensembl chr 2:166,888,480...167,259,753
G
XRCC1
X-ray repair cross complementing 1
multiple interactions
ISO
Pioglitazone inhibits the reaction [LEPR protein affects the expression of XRCC1 protein]
CTD
PMID:35472412
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
G
YIPF7
Yip1 domain family member 7
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of YIPF7 mRNA
CTD
PMID:27935865
NCBI chr 4:44,622,088...44,662,199
Ensembl chr 4:44,622,088...44,678,556
G
ZC3H11A
zinc finger CCCH-type containing 11A
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]
CTD
PMID:20847119
NCBI chr 1:203,795,623...203,854,124
Ensembl chr 1:203,795,623...203,854,999
G
ZCCHC18
zinc finger CCHC-type containing 18
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZCCHC18 mRNA
CTD
PMID:27935865
NCBI chr X:104,112,523...104,115,842
Ensembl chr X:104,112,131...104,115,842
G
ZCWPW1
zinc finger CW-type and PWWP domain containing 1
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZCWPW1 mRNA
CTD
PMID:27935865
NCBI chr 7:100,400,872...100,428,703
Ensembl chr 7:100,400,826...100,428,992
G
ZDBF2
zinc finger DBF-type containing 2
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZDBF2 mRNA
CTD
PMID:27935865
NCBI chr 2:206,274,663...206,314,427
Ensembl chr 2:206,274,663...206,314,427
G
ZFP36
ZFP36 ring finger protein
multiple interactions
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA
CTD
PMID:20847119
NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,412
G
ZKSCAN4
zinc finger with KRAB and SCAN domains 4
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZKSCAN4 mRNA
CTD
PMID:27935865
NCBI chr 6:28,241,697...28,259,211
Ensembl chr 6:28,241,697...28,252,269
G
ZNF117
zinc finger protein 117
multiple interactions
EXP
Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF117 mRNA]
CTD
PMID:20847119
NCBI chr 7:64,971,772...64,991,036
Ensembl chr 7:64,971,772...65,006,684
G
ZNF354C
zinc finger protein 354C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZFP354C mRNA
CTD
PMID:27935865
NCBI chr 5:179,060,373...179,083,977
Ensembl chr 5:179,060,373...179,083,977
G
ZNF385C
zinc finger protein 385C
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZFP385C mRNA
CTD
PMID:27935865
NCBI chr17:42,025,576...42,098,473
Ensembl chr17:42,025,576...42,098,479
G
ZNF454
zinc finger protein 454
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZFP454 mRNA
CTD
PMID:27935865
NCBI chr 5:178,941,198...178,990,028
Ensembl chr 5:178,941,191...178,966,433
G
ZNF521
zinc finger protein 521
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZFP521 mRNA
CTD
PMID:27935865
NCBI chr18:25,061,924...25,352,166
Ensembl chr18:25,061,924...25,352,190
G
ZNF641
zinc finger protein 641
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZFP641 mRNA
CTD
PMID:27935865
NCBI chr12:48,334,587...48,351,246
Ensembl chr12:48,337,180...48,351,414
G
ZNF681
zinc finger protein 681
multiple interactions
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF681 mRNA]
CTD
PMID:20847119
NCBI chr19:23,739,195...23,758,891
Ensembl chr19:23,739,195...23,758,891
G
ZPBP
zona pellucida binding protein
multiple interactions
ISO
[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZPBP mRNA
CTD
PMID:27935865
NCBI chr 7:49,840,654...50,093,246
Ensembl chr 7:49,850,421...50,121,329
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all